Skip Ribbon Commands
Skip to main content

Publications

Below is a list of citations of original articles pertaining to research that was conducted as part of the Collaboration for AIDS Vaccine Discovery.
Please click on the title to see more information about the article, read its abstract, and link to the article’s record in PubMed.

In January 2015, the Bill & Melinda Gates Foundation adopted an Open Access policy that enables the unrestricted access and reuse of all peer-
reviewed published research funded, in whole or in part, by the foundation, including any underlying data sets. The action stems from the
commitment to information sharing and transparency.
Learn more here...

  
  
  
  
  
  
  
Antibody 10-1074 suppresses viremia in HIV-1-infected individualsCaskey, MarinaNature Medicine20171/16/201728092665Link to full-text
Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.MacMaster PPElsevier20171/3/201727899229Link to full-text
Diversity of antiviral IgG effector activities observed in HIV-infected and vaccinated subjects. Huang, Y.Journal of Immunology201612/15/201627913647Link to full-text
Inhibitory receptor expression on memory CD8 T cells following Ad vector immunizationPenaloza-MacMaster, PabloVaccine20169/22/201627566899Link to full-text
Tailored Immunogens Direct Affinity Maturation Toward HIV Neutralizing AntibodiesBriney B.Cell20169/8/201627610570Link to full-text
Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells Provine, Nicholas M. Journal of Immunology20169/7/201627448585Link to full-text
Epitope-independent purification of native-like envelope trimerVerkerke, Hans P.Journal of Virology20168/10/201627512064Link to full-text
Changes in structure and antigenicity of HIV-1 Env trimers resulting from removal of a conserved CD4 binding site-proximal glycanLiang YJ Virology20168/3/2016Link to full-text
Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing AntibodiesDavenport, TMStructure20167/20/2016Link to full-text
Induction of heterologous Tier 2 HIV-1 neutralizing and cross-reactive V1/V2-specific antibodies in rabbits by prime-boost immunization.Townsley, SJ Virology20167/20/2016Link to full-text
Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: Implications for active and passive immunization.Rademeyer, C.PLoS Pathogens20167/19/20161005742Link to full-text
Novel Monoclonal Antibodies for Studies of Human and Rhesus Macaque Secretory Component and Human J-ChainZhang, RuijunMonoclonal Antibodies in Immunodiagnosis and Immunotherapy20167/7/201627386924Link to full-text
Bispecific antibodies against HIVMontefiori, D. C. Cell20166/16/201627315470Link to full-text
Transient CD4 T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody ResponsesNicholas M. ProvineJournal of Virology20165/1/201626865713Link to full-text
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineagesZhang, RuijunScience Translational Medicine20164/27/2016Link to full-text
Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody RecognitionY LiangBiochemistry20164/19/2016Link to full-text
Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody ResponsesProvinea, Nicholas M. Journal of Virology20164/14/201626865713Link to full-text
Optimal combinations of broadly neutralizing antibodies for prevention and treatment of HIV-1 clade C infection. Wagh, K.PLoS Pathogens20163/30/201627028935Link to full-text
A germline-targeting immunogen isolates HIV broadly neutralizing antibody precursors from HIV-uninfected donorsJardine JGScience20163/25/201627013733Link to full-text
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope GlycoproteinBehrens AJCell Reports20163/22/201626972002Link to full-text
Lower Viral Loads and Slower CD4 Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.Leitman, EMJournal of Infectious Diseases20163/16/201626951820Link to full-text
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer.Lee, JHScience20163/4/201626941313Link to full-text
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyBonsignori MCell20163/2/201626949186Link to full-text
Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. Kloverpris, HNImmunity20162/16/201626850658Link to full-text
Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex EHansen, Scott G.Science20162/12/201626797147Link to full-text
Streamlining Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.Asbach BJournal of Virology20162/1/2016Link to full-text
HIV-specific CD8+ T cells and HIV eradication.Jones, R.B. & Walker, B.D.Journal of Clinical Investigation20162/1/201626731469Link to full-text
HIV-1 integration landscape during latent and active infectionCohn, LBCell20161/29/201625635456Link to full-text
Broadly targeted CD8(+) T cell responses restricted by major histocompatibility complex E. SciencePicker, Louis, JScience20161/23/201626797147Link to full-text
Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane Fusion.Garcia, NKViruses20161/11/201626761026Link to full-text
Lamba Light Chain Bias Associated with Enhanced Binding and Function of Anti-HIV Env Glycoprotein AntibodiesSajadi MMCurrent HIV Research20161/1/2016Link to full text
Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC ResponsesVeillette, MaximeCurrent HIV Research20161/1/201626310828Link to full-text
Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.Alsahafi, NJournal of Virology201512/30/2015Link to full-text
Structure-guided redesign increases the propensity of HIV Env to generate highly stable soluble trimersGuenaga JJournal of Virology201512/30/201526719252Link to full-text
Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study. Byrne, E.H.Lancet Infectious Disease201512/23/201526723758Link to full-text
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design.Gorman, JNature Structural & Molecular Biology201512/21/201526689967Link to full-text
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes de Taeye SWCell201512/17/201526687358Link to full-text
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.de Taeye, SWCell201512/17/201526687358Link to full-text
Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding GlycansGarces FJournal of Immunity201512/15/201526682982Link to full-text
Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikesNakatani-Webster, EJournal of Virological Methods201512/15/2015Link to full-text
MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing dataFinak GGenome Biology201512/10/201526653891Link to full-text
HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses.Ranasinghe, S.Journal of Virology201512/9/201526656715Link to full-text
Optimized replicating Renilla luciferase reporter HIV-1 utilizing novel Internal Ribosome Entry Site elements for native Nef expression and functionAlberti, M.O. AIDS Research & Human Retroviruses 201512/1/201526101895Link to full-text
Analyzing Peptide Microarray Data with the R pepStat PackageImholte GMethods in Molecular Biology201512/1/201526490472Find in Springer
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein TrimersRinge RP Journal of Virology201512/1/201526311893Link to full-text
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein TrimersRinge RPJournal of Virology201512/1/201526311893 Link to full-text
Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.Mclaren, PJProceedings of the National Academy of Sciences USA201511/24/201526553974Link to full-text
Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.Tan WGJournal of Virology201511/21/201523175355 Link to full text
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design1) Andrabi R., Journal of Immunity201511/17/201526588781Link to full-text
T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African AdolescentsSeshadri CThe Journal of Immunology201511/15/201526466957 Link to full-text
Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors.Penaloza-MacMaster PJournal of Virology201511/14/201523152535 Link to full text
Modulating the durability of anti-HIV gp120 antibody responses after vaccination: a comment on Wilson & Karp (2015)DeVico ALPhilosophical Transactions of the Royal Society B201511/5/2015Link to full-text
Modulating the durability of anti-HIV gp120 antibody responses after vaccination: a comment on Wilson & Karp (2015)DeVico, Anthony L.Philos Trans R Soc Lond B Biol Sci201511/5/201526460138Link to full-text
The role of Fc receptors in HIV prevention and therapyBoesch AWImmunological Reviews201511/1/201526497529Link to full-text
The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic propertiesLorenz ICAIDS Research and Human Retroviruses 201511/1/201524597516Link to full-text
Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by VectorizationMaxfield LFClinical and Vaccine Immunology201511/1/2015Link to full-text
The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.Ndhlovu, ZMJournal of Virology201511/1/201526269189Link to full-text
Chemical Cross-linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer AntigensSchiffner T Journal of Virology201510/28/201526512083Link to full-text
Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer AntigensSchiffner TJournal of Virology201510/28/201526512083Link to full-text
The conserved role of an N-linked glycan on the surface antigen of HIV-1 modulating virus sensitivity to broadly neutralizing antibodies against the receptor and coreceptor binding sitesTownsley, SJournal of Virology201510/28/2015Link to full-text
Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein TrimerSliepen K Biomolecules201510/23/201526512709Link to full-text
Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein TrimerSliepen KBiomolecules201510/23/201526512709Link to full-text
Synthetic nanoparticles for vaccines and immunotherapyIrvine, D.J.Chemical Reviews201510/14/2015    26154342Link to full-text
Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th CellsStorcksdieck Genannt Bonsmann, MichaelThe Journal of Immunology201510/14/201526466954Link to full-text
Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy.Lee JH Structure201510/6/201526388028Link to full-text
Ion Mobility Mass Spectrometry for Ion Recovery and Clean-Up of MS and MS/MS Spectra Obtained from Low Abundance Viral SamplesHarvey DJJournal of the Americal Society of Mass Spectromitry201510/1/201526204966Link to full-text
Model building and refinement of a natively glycosylated HIV-1 Env protein by high-resolution cryoelectron microscopyLee JHStructure201510/1/201526388028Link to full-text
Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodiesWebb, Nicholas E.Nature Communications20159/29/201526416571Link to full-text
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicitySliepen K Retrovirology20159/26/201526410741 Link to full-text
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike prior to receptor bindingLee JHNature Communications20159/25/201526404402Link to full-text
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogensJulien JPProceedings of the National Academy of Sciences of the United States of America20159/22/201526372963Link to full-text
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogensJulien J-PProceedings of the National Academy of Science20159/22/201526372963Link to full-text
Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1Lewis GKViruses20159/18/2015Link to full-text
Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1.Lewis, George K.Viruses20159/18/201526393642Link to full-text
Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point.Ndhlovu, ZMImmunity20159/15/201526362266Link to full-text
Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 EnvScharf, LCell20159/10/201526359989Link to full-text
Lambda light chain bias associated with enhanced binding and function of anti-HIV Env glycoprotein antibodiesSajadi MMThe Journal of Infectious Disease20159/7/201526347575Link to full-text
Lambda light chain bias associated with enhanced binding and function of anti-HIV Env glycoprotein antibodiesSajadi MMThe Journal of Infectious Disease20159/7/201526347575Link to full-text
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein AntibodiesSajadi, Mohammad M.Journal of Infectious Diseases20159/7/201526347575Link to full-text
Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1Gohain NJournal of Virology20159/1/2015Link to full-text
Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1Gohain, NeelakshiJournal of Virology20159/1/2015PMC4524080Link to full-text
Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 EnvelopePritchard, L., K.Journal of Virology20159/1/201526085151Link to full text
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicitySliepen KRetrovirology20159/1/201526410741Link to full-text
Vaccine induced epitope specific antibodies to SIVmac239 envelope are distinct from those induced to the HIV-1 envelope in non-human primates. Shen, X.Journal of Virology20158/15/201526018159Link to full text
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal AntibodiesMcCoy, Laura, E.PLoS Pathogens20158/12/201526267277Link to full-text
Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificityHu, Joyce, K.Journal of Virology 20158/5/201526246566Link to full text
Head-to-head comparison of poxvirus NYVAC and ALVAC vectors expressing identical HIV-1 clade C immunogens in prime/boost combination with Env protein in non-human primates. Garcia-Arriaza, JuanJournal of Virology20158/3/201526041302Link to full-text
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques.Santra, Sampa PLOS Pathogens 20158/3/201526237403Link to full-text
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques Santra, SampaPLos Pathogogens20158/3/201526237403Link to full-text
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman PrimateShen XJournal of Virology20158/1/2015Link to full-text
Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin proteinZhang XVirology20158/1/2015 25880113Link to full-text
Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunityKorioth-Schmitz, BirgitVaccine20157/17/201526192357Link to full-text
HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition. Prentice, H.Science Translational Medicine20157/15/201526180102Link to full-text
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.Sanders, RWScience20157/10/201526089353Link to full-text
Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosisBerney, MichaelProceedings of the National Academy of Sciences of the United States of America20157/8/201526221021Link to full-text
Isotope Labeling of Biomolecules: Structural Analysis of Viruses by HDX-MSGuttman, MMethods Enzymology20157/4/201526791988Link to full-text
Protective efficacy of adenovirus-protein vaccines against SIV challenges in rhesus monkeysBarouch DHScience20157/2/201526138104Link to full-text
Determination of N-linked glycosylation in viral glycoproteins by negative ion mass spectrometry and ion mobilityBitto, D.Methods in Molecular biology20157/1/201526169737Link t full text
Glycan remodelling with processing inhibitors and lectin-resistant eukaryotic cellsGlycan Chang, V., T.Methods in Molecular biology20157/1/201526082231Link to full text
Immunogenic Display of Purified Chemically Cross-Linked HIV-1 SpikesLeaman DP Journal of Virology 20157/1/201525878116Link to full-text
Immunogenic Display of Purified Chemically Cross-Linked HIV-1 SpikesLeaman DPJournal of Virology20157/1/2015 25878116Link to full-text
Glycan microheterogeneity at the PGT135 antibody recognition site on HIV-1 gp120 reveals a molecular mechanism for neutralization resistancePritchard, L., K.Journal of Virology20157/1/201525878100Link to full text
CATNAP: a tool to compile, analyze, and tally neutralizing antibody panels. Yoon, H. Nucleic Acids Research 20157/1/201526044712Link to full text
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Caskey, MNature20156/25/2015Link to full-text
Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodiesPritchard, L., K.Nature Communications20156/24/201526105115Link to full text
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env.Kwon, YDNature Structural and Molecular Biology20156/22/201526098315Link to full-text
Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo StudiesLatinovic Olga SAIDS Research and Human Retroviruses20156/22/201526059995Link to full-text
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccineeNicely, NathanEBioMedicine20156/20/201526288844Link to full-text
Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice. Dosenovic, P.Cell20156/18/2015 26091035Link to full-text
HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogenJardine, J., G.Science20156/18/2015 26089355Link to full text
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers Sanders, R., W.Science20156/18/201526089353Link to full text
Structural constraints determine the glycosylation of HIV-1 envelope trimersPritchard, L., K.Cell Reports20156/16/201526051934Link to full text
Microscale purification of antigen-specific antibodiesBrown EPThe Journal of Immunological Methods20156/12/201526078040Link to full-text
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein BoostHulot, Sandrine L Journal of Virology20156/12/201525855741Link to full-text
Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers.Martin-Gayo, EPLoS Pathogens20156/11/201526067651Link to full-text
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsZhou, TCell20156/4/201526004070Link to full-text
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvantsHanson, M.C.Journal of Clinical Investigation20156/1/201525938786Link to full-text
COMPASS identifies T-cell subsets correlated with clinical outcomesLin LNature Biotechnology20156/1/201526006008 Link to full-text
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding SiteCrooks, E., T.Plos Pathogens20155/29/201526023780 Link to full text
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman PrimatesShen XJournal of Virology20155/27/2015Link to full-text
Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo StudiesLatinovic LAIDS Research and Human Reteroviruses20155/26/2015Link to full-text
Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract.Anahtar, MNImmunity20155/19/201525992865Link to full-text
Comparative glycoprofiling of HIV gp120 immunogens by capillary electrophoresis and MALDI mass spectrometry.Guttman, MElectrophoresis20155/15/201525809283Link to full-text
Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunizationPhad, G., E.Journal of Immunology20155/11/201525964491Link to full text
Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.Bandawe, G. Journal of Infectious Diseases20155/1/201525398460Link to full text
Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant BCG VectorsHart, Bryan  E.Clinical Vaccine and Immunology20154/29/201525924766Link to full-text
Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine designSharma SK Cell Reports20154/28/201525892233Link to full-text
Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine designSharma, S., K.Cell20154/28/201525892233 Link ot full text
Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry dataLin LCytometry Part A20154/23/201525908275Link to full-text
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: Complete protection of rhesus monkeys from mucosal SHIV challengeAnton SholukhVaccine20154/21/201525769884Link to full-text
Potent functional antibody responses elicited by HIV-1 DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults. Joachim, A.PLoS One20154/14/201525874723Link to full text
Interleukin-1- and Type I Interferon-Dependent Enhanced Immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef Vaccine Vector with Dual Deletions of Type I and Type II Interferon-Binding ProteinsDelaloye, JJournal of Virology20154/5/2015PMC4403427Link to full-text
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine designCrispin, M.Current Opinion in Virology20154/1/201525747313Link to full text
Conserved Molecular Signatures in gp120 Are Associated with the Genetic Bottleneck during Simian Immunodeficiency Virus (SIV), SIV-Human Immunodeficiency Virus (SHIV), and HIV Type 1 (HIV-1) TransmissionGonzalez, MileidyJournal of Virology20154/1/201525589663Link to full-text
Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimerDerking RPLoS Pathogens20153/25/201525807248Link to full-text
Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer Derking RPLos Pathogen20153/25/201525807248Link to full-text
Antigenic Properties of the Human Immunodeficiency Virus Envelope Glycoprotein Gp120 on Virions Bound to Target CellsMengistu, MeronPLOS Pathogens20153/25/201525807494Link to full-text
High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.Gounder, KPLos One20153/17/201525781986Link to full-text
Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulationMartinez, P.Science Reports20153/12/201525762407Link to full text
Antibody engineering for increased potency, breadth and half-lifeSievers, Stuart, ACurrent Opinion in HIV and AIDS20153/10/201525760931Link to full-text
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionFouts TRProceedings of the National Academy of Sciences of the United States of America20153/3/2015Link to full-text
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionFouts, TProceedings of the National Academy of Sciences20153/3/2015Link to full-text
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionFouts, TimothyProceedings of the National Academy of Sciences20153/3/201525681373Link to full-text
A multivalent clade C HIV-1 env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component. Bricault, C.A.Journal of Virology20153/2/201525540368Link to full-text
Development of a duplex real-time RT-qPCR assay to monitor genome replication, gene expression and gene insert stability during in vivo replication of a prototype live attenuated canine distemper virus vector encoding SIV gagColeman JWJournal Virological Methods 20153/1/201525486083Link to full-text
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes.Kong, R. Journal of Virology20153/1/201525520506Link to Full Text
A native-like SOSIP.664 trimer based on an HIV-1 subtype B env genePugach PJournal of Virology20153/1/201525589637 Link to full-text
Prospects for engineering HIV-specific antibodies for enhanced effector function and half-lifeBoesch AWCurrent Opinion in HIV and AIDS20152/19/201525700208Link to full-text
Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 VaccineesChoi IPLoS Computational Biology20152/15/201525874406Link to full-text
Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptidesHanson, M.C.Vaccine20152/11/201525559188Link to full-text
Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptidesHanson, Melissa C.Vaccine20152/11/201525559188Link to full-text
Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIVGuttman, MNature Communications20152/5/2015Link to full-text
Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trialEdlefsen, PPLoS Computational Biology20152/3/201525646817Link to full-text
Generation and evaluation of clade C Simian-Human Immunodeficiency Virus challenge stocks. Chang, H.W. Journal of Virology20152/2/201525473043Link to full-text
B cell follicle sanctuary permits persistent productive SIV infection in elite controllersFukazawa YNature Medicine20152/1/201525599132 Link to full-text
A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresisMahan AEJournal of Immunological Methods20152/1/201525523925Link to full-text
Intra-Spike Crosslinking Overcomes Antibody Evasion by HIV-1.Galimidi, R, PCell20151/29/201525635457Link to Full Text
Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infectionPenaloza-MacMaster PScience20151/16/2015Link to full-text
Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopesAsmal, MohammedVirology20151/15/201525462344Link to full-text
Conserved molecular signatures in gp120 are associated with the genetic bottleneck during SIV, SHIV, and HIV-1 transmissionGonzalez MWJournal of Virology20151/14/2015Link to full-text
Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like propertiesGuenaga,  J.Plos Pathogens20151/8/201525569572Link to full text
Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infectionRadebe, MAIDS20151/2/201525387316Link to full-text
Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine developmentStephenson KEJournal of Immunological Methods20151/1/2015Link to full-text
Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine developmentStephenson KEQuantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development.20151/1/2015Link to full-text
Molecular evolution of broadly neutralizing llama antibodies to CD4-binding site of HIV-1. McCoy, L. E. PLoS Pathogens201412/18/201425522326Link to full-text
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.Wiehe, KevinImmunity201412/18/2014    25526306Link to full text
A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresisMahan AEThe Journal of Immunological Methods201412/15/201425523925Link to full-text
Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodiesIngale JJournal of Virology201412/1/2014Link to Full Text
Gene Deletions in BCG Stimulate 1 Increased CD8+ T Cell ResponsesPanas, Michael WInfection and Immunity201412/1/201425287928Link to full-text
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apexSok DProceeding of the National Academy of Science201412/1/201425422458Link to Full Text
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaquesThomas MAVirology201412/1/2014Link to full-text
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaquesThomas, MichaelVirology201412/1/201425461534Link to full-text
Construction and Evaluation of Novel Rhesus Monkey Adenovirus Vaccine VectorsAbbink, PJournal of Virology201411/19/2014Link to full-text
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants. Klein, F. Journal of Experimental Medicine201411/17/201425385756Link to full-text
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interfaceHuang JNature201411/6/201425186731Link to full-text
Antibody persistence and T-cell balance: two key factors confronting HIV vaccine developmentLewis, George K.Proc Natl Acad Sci U S A201411/4/201425349379Link to full-text
Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 InfectionAcharya PJournal of Virology201411/1/2014Link to Full-Text
HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profileForsell MNAIDS Res Hum Retroviruses201411/1/201425245278Link to Full Text
Vaccine-induced human antibodies specific for the third variable region of HIV-1 gp120 impose immune pressure on infecting virusesZolla-Pazner SeBioMedicine201411/1/201425599085Link to full-text
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as VLPsPerdiguero, BeatrizJournal of virology201410/29/2014Link to full-text
Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development.Lewis GKProfessional Proceedings of the National Academy of Sciences of the United States201410/27/2014Link to full-text
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1Lai, R.P. The Journal of Biological Chemistry 201410/24/201425160627Link to full text
Impact of clade, geography and age of the epidemic on HIV-1 neutralization by antibodies. Hraber, P. Journal of Virology201410/6/201425142591Link to full text
Aggregate complexes of HIV-1 induced by multimeric antibodiesStieh, Daniel JRetrovirology201410/2/2014    25274446Link to full-text
Aggregate complexes of HIV-1 induced by multimeric antibodiesStieh, Daniel JRetrovirology201410/2/201425274446Link to full-text
Design and characterization of structured protein linkers with differing flexibilitiesKlein, Joshua, SProtein Engineering Design and Selection201410/1/201425301959Link to full-text
Structural evolution of glycan recognition by a family of potent HIV antibodiesGarces, F.Cell20149/25/201425259921Link to full text
Improving Mycobacterium bovis Bacillus Calmette-Guerin as a vaccine delivery Vector for viral antigens by incorporation of glycolipid activators of NKT cellsVenkataswamy, Manjunatha MPLoS one20149/25/201425255287Link to full-text
Noncanonical SMC protein in Mycobacterium smegmatis restricts maintenance of Mycobacterium fortuitum plasmidsPanas, Michael WProceedings of the National Academy of Sciences20149/16/201425197070Link to full-text
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. Bournazos, S.Cell 20149/11/201425215485Link to full-text
Structural evolution of glycan recognition by a family of potent HIV antibodiesGarces F., Cell20149/1/2014Link to Full Text
Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopyMurin CDJournal of Virology20149/1/201424965454Link to Full text
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimerNkolola JPJournal of Virology20149/1/2014Link to full-text
Characterization and Immunogenicity of a Novel Mosaic M HIV-1 gp140 TrimerNkolola, Joseph P.Journal of Virology20149/1/2014Link to full-text
Envelope glycoprotein binding to the α4β7 integrin complex is not a general property of most HIV-1 strains. Perez, L.G.Journal of Virology20149/1/201425008916Link to full-text
OpenCyto: an open source infrastructure for scalable, robust, reproducible, and automated, end-to-end flow cytometry data analysisFinak GPLos Computational Biology20148/28/201425167361Link to full-text
Structural Definition of an Antibody-Dependent Cellular Cytotoxicity (ADCC) Response Implicated in Reduced Risk for HIV-1 InfectionAcharya, PriyamvadaJournal of Virology20148/27/201425165110Link to full-text
Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector functionChung AWAIDS20148/26/201425160934Link to full-text
Live Attenuated and Inactivated Influenza Vaccines in ChildrenIlyushina NAThe Journal of Infectious Disease20148/26/201425165161Link to full-text
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo Rudicell, Rebecca S.Journal of Virology20148/20/201425142607Link to full-text
Rational Design and Characterization of the Novel, Broad and Potent Bispecific HIV-1 Neutralizing Antibody iMabm36Sun, MingJournal of Acquired Immune Deficiency Syndromes20148/15/201424853313Link to full-text
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized miceHalper-Stromberg ACell20148/14/201425131989Link to full-text
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionKo, Sung-YoulNature20148/13/201425119033Link to full-text
Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trialGartland AJJournal of Virology20148/1/201424829343Link to full-text
Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy. Montefiori, D.C.Human Vaccines & Immunotherapeutics20148/1/201424784350Link to full-text
HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunizationNavis M, Plos Pathogen20148/1/201425166308Link to full-text
Recombinant Bacillus Calmette-Guérin vectors prime for strong cellular responses to SIV Gag in rhesus macaquesSixsmith, Jaimie DClinical and Vaccine Immunology20148/1/201425080550Link to full-text
Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectorsTeigler JEClinical and Vaccine Immunology20148/1/2014Link to full-text
Modeling bi-modality improves characterization of cell cycle on gene expression in single cellsMcDavid APLoS Computational Biology20147/17/201425032992Link to full-text
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities. Pollara, J.Journal of Virology20147/15/201424807721Link to full-text
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities.Pollara, JustinJournal of Virology20147/15/201424807721Link to FullText
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral ActivitiesPollara, Justin Journal of Virology 20147/14/201424807721Link to full-text
Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infectionDugast ASThe European Journal of Immunology20147/10/201425043633Link to full-text
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptorPegu, Amarendra Science Translational Medicine20147/2/201424990883Link to full-text
Highly parallel characterization of IgG Fc binding interactionsBoesch AWMAbs20147/1/201424927273Link to full-text
Corrigendum: Systemic vaccination induces clonally diverse SIV-specific CD8+ T-cell populations in systemic and mucosal compartmentsSircar, PiyaMucosal Immunology20147/1/201424934122Link to full-text
Nonlinear Calibration Model Choice between the Four and Five Parameter Logistic Models.Cumberland WNJournal of Biopharmaceutical Statistics20146/11/201424918306Link to full-text
Vaccine-Induced HIV-1 Envelope gp120 Constant Region 1-Specific Antibodies Expose a CD4-Inducible Epitope and Block the Interaction of HIV-1 gp140 with GalactosylceramideDennison, S MosesJournal of Virology20146/11/2014    24920809Link to full-text
CD4-Induced Activation in a Soluble Env TrimerGuttman, MiklosStructure20146/11/2014Link to full-text
A Role for Gr-1+ Cells in the Control of High-dose rBCGPanas, Michael WClinical and Vaccine Immunology20146/11/201424920602Link to full-text
Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programsGarcia, AmbrosiaJournal of Immunological Methods20146/10/201424928650Link to full-text
Specialized Transduction Designed for Precise High-Throughput Unmarked Deletions in Mycobacterium tuberculosisJain, ParasmBio20146/3/201424895308Link to full-text
CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodiesMadani N, Journal of Virology20146/1/201424696475Link to full-text
Enhanced Specialized Transduction Using Recombineering in Mycobacterium tuberculosisTufariello, JoAnn MmBio20145/27/201424865558Link to full-text
Lack of Protection following Passive Transfer of Polyclonal Highly Functional Low-Dose Non-Neutralizing AntibodiesDugast ASPLoS One20145/12/201424820481Link to full-text
Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spikeScharf, LouiseCell Reports20145/8/201424767986Link to full-text
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral ActivitiesPollara, JustinJournal of Virology20145/7/2014    24807721Link to full text
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimersBlattner CImmunity20145/1/2014PMC405701Link to full-text
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.Doria-Rose, N.ANature20145/1/201424590074Link to full-text
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimersFalkowska EImmunity20145/1/201424768347Link to full-text
Epitope target structures of Fc-mediated effector function during HIV-1 acquisition: Curr Opin HIV AIDSLewis GKCurrent Opinion in HIV and AIDS20145/1/2014Link to full-text
Epitope target structures of Fc-mediated effector function during HIV-1 acquisitionLewis, George K.Current Opinion in HIV and AIDS.20145/1/201424670318Link to full-text
Role of Fc-mediated antibody function in protective immunity against HIV-1.Lewis, George K.Immunology20145/1/201424843871Link to full-text
Role of Fc-mediated antibody function in protective immunity against HIV-1Lewis, George K.Immunology20145/1/201424843871Link to full-text
Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIVSok DScience Translational Medicine20145/1/201424828077Link to full-text
Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trialsSambor, AnnaJournal of Immunological Methods20144/29/201424787274Link to full-text
Role of Fc-mediated antibody function in protective immunity against HIV-1Lewis, GKImmunology20144/10/2014Link to full-text
T follicular helper cells and HIV/SIV-specific antibody responsesPetrovas, ConstantinosCurrent Opinion in HIV & AIDS20143/25/201424670319Link to full-text
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 VaccinesChung, Amy W. Science Translational Medicine20143/19/201424648341Link to full-text
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Yates, N.L. Science Translational Medicine20143/19/201424648342Link to full-text
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccinationYates, NicoleScience Translational Medicine20143/19/2014    24648342Link to full text
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccinationYates, Nicole LScience Translational Medicine20143/19/2014    24648342Link to full-text
Optimization and Validation of a Neutralizing Antibody Assay for HIV-1 in A3R5 Cells. Sarzotti-Kelsoe, M. Journal of Immunological Methods 20143/6/201424607608Link to full-text
Disruption of helix-capping residues 671 and 674 reveals a role in HIV-1 entry for a specialized hinge segment of the membrane proximal external region of gp41Sun, Zhen-Yu Journal of Molecular Biology20143/6/201424075869Link to full-text
Advancing toward HIV-1 vaccine efficacy through the intersections of immune correlates. Tomaras, G.D. Vaccines20143/3/201424932411Link to full-text
Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune CorrelatesTomaras, Georgia DVaccines (Basel)20143/2/201424932411Link to full-text
Global Panel of HIV-1 Env reference strains for standardized assessment of vaccine-elicited neutralizing antibodiesDeCamp AJournal of Virology20143/1/201424352443Link to full-text
High-throughput flow cytometry data normalization for clinical trials.Finak GCytometry A20143/1/201424382714Link to full-text
Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated CytotoxicityVeillette, MaximeJournal of Virology20143/1/201424352444Link to full-text
HIV-1 persistence in CD4+ T cells with stem cell-like properties.Buzon, M.J.Nature Medicine20142/20/201424412925Link to full-text
Capacity for infectious HIV-1 virion capture differs by envelope antibody specificityLiu, PinghuangJournal of Virology20142/14/201424554654Link to full-text
Structural insights on the role of antibodies in HIV-1 vaccine and therapyWest APCell20142/13/201424529371Link to full-text
Structural insights on the role of antibodies in HIV-1 vaccine and therapyWest, Jr., Anthony, P.Cell20142/13/201424529371Link to full-text
Vaccine-induced IgC antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infectionZolla-Pazner SPLos One20142/4/201424504509 Link to full-text
Vaccine-induced IgC antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infectionZolla-Pazner SPLos One20142/4/201424504509Link to full-text
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infectionZolla-Pazner, SusanPLoS One20142/4/2014    24504509Link to full-text
Antigenic properties of the HIV envelope on virions in solutionRay KJournal of Virology20142/1/2014Link to full-text
Antigenic properties of the HIV envelope on virions in solution.Ray, KrishanuJournal of Virology20142/1/201424284318Link to full-text
Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesignTran KProceeding of the National Academy of Science20142/1/20142455031Link to full-text
Loss of Circulating CD4 T Cells with B Cell Helper Function during Chronic HIV InfectionBoswell, Kristin, LPLOS Pathogens20141/30/201424497824Link to full text
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIVRoederer MNature20141/23/201424352234Link to full-text
Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral VaccinationWright PFThe Journal of Infectious Disease20141/23/201424459191Link to full-text
Prevalence of Broadly Neutralizing Antibody Responses during Chronic HIV-1 Infection. Hraber, P.AIDS20141/14/201424361678 Link to full-text
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing AntibodiesdeCamp AJournal of Virology201312/20/20132435244Link to full-text
Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers.Lai, JenniferJournal of Virology201312/18/201324352471Link to full-text
Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated CytotoxicityVeillette MJournal of Virology201312/18/2013Link to full-text
Broadly neutralizing antibodies that inhibit HIV-1 cell-to-cell transmissionMalbec MJournal of Experimental Medicine201312/16/201324277152Link to full-text
Protective efficacy of a global HIV-1 mosaic vaccine against acquisition of heterologous SHIV challenges in rhesus monkeysBarouch DHCell201312/13/201324243013 Link to full-text
Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12Wu, YunjiCell Reports201312/12/201324316082Link to full-text
Allosteric induction of the CD4-bound conformation of HIV-1 Gp120Roitburd-Berman ARetrovirology201312/5/2013Link to full-text
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models. Lacerda, M. Virology Journal 201312/2/201324295501 Link to full-text
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. Sarzotti-Kelsoe, M. Journal of Immunological Methods201312/2/201324291345Link to full-text
Mitigation of variation observed in peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling. Wieczorek, L.Virology201312/2/2013 24210120Link to full-text
Allosteric induction of the CD4-bound conformation of HIV-1 Gp120.Roitburd-Berman, AnnaRetrovirology201312/1/201324304511Link to full-text
Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone. PLoS One, 8(11):e76104. Chenine, A.L. PLoS One201311/29/201324312165Link to full-text
Detection of HIV-1 Neutralizing Antibodies in a Human CD4(+)/CXCR4(+)/CCR5(+) T-Lymphoblastoid Cell Assay System. McLinden, R.J. PLoS One201311/28/201324312168Link to full-text
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responsesNaarding, Marloes, AJournal of Immunological Methods201311/28/201324291126Link to Full Text
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Barouch DHNature201311/14/201324172905 Link to full-text
Antibody mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemiaShingai MNature201311/14/201324172896Link to full-text
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestorsAlam, S MunirProceedings of the National Academic of Sciences201311/5/2013    24145434Link to full-text
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysBarouch DHNature201310/30/201324172905 Link to full-text
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.Barouch DHNature201310/30/201324172905 Link to full text
A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates.Padte, NNPLOS One201310/25/201324205224Link to full-text
Protective efficacy of a global HIV-1 mosaic vaccine against acquisition of heterologous SHIV challenges in rhesus monkeysBarouch DHCell201310/24/201324243013 Link to full-text
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.Barouch DHJournal of Virology201310/24/201324243013 Link to full text
GagPol-specific CD4+ T-cells increase the antibody response to Env by intrastructural helpNabi GRetrovirology201310/24/201324156704 Link to full-text
GagPol-specific CD4+ T-cells increase the antibody response to Env by intrastructural helpNabi, GhulamRetrovirology201310/24/2013Link to full-text
nCal: a R package for nonlinear calibration Fong YBioinformatics201310/15/201323926226Link to full-text
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized miceHorwitz JAProceedings of the National Academy of Sciences201310/8/201324043801Link to full-text
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activitySong, RuijiangNature Biotechnology201310/6/201324097413Link to full-text
Immune clearance of highly pathogenic SIV infectionHansen SGNature201310/3/201324025770Link to full-text
Immune clearance of highly pathogenic SIV infectionHansen, Scott G.Nature201310/3/201324025770Link to full-text
Differential Binding of IgG and IgA to Mucus of the Female Reproductive TractFahrbach, KellyPLoS One201310/2/201324098437Link to full-text
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 as a correlates of infection risk in the RV144 vaccine efficacy trial.Gottardo, R. PLoS One20139/30/201324086607Link to full-text
A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profilingImholte, G. Journal of  Immunological Methods20139/30/201323770318Link to full-text
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial.Gottardo RPLoS One.20139/26/201324086607Link to full-text
Generation of effector memory T-cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccinationLi AVScience20139/25/201324068737 Link to Full-Text
Antibodies in HIV-1 vaccine development and therapyKlein FScience20139/13/201324031012Link to full-text
A Multiplexed Assay to Detect Antimicrobial Peptides in Biological Fluids and Cell SecretionsBoesch AWThe Journal of Immunological Methods20139/10/201324035708Link to full-text
Sieve analysis in HIV-1 vaccine efficacy trials.Edlefsen PTCurrent Opinions on HIV and AIDS20139/8/201323719202Link to full-text
Frozen cells and bits: cryoelectronics advances biopreservation.Ihmig FRIEEE Pulse. 2013 Sep;4(5):35-43. doi: 10.1109/MPUL.2013.2271685.20139/1/2013    24056792Link to Full-Text
A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen designLu, ShanJournal of Virology20139/1/201323864612Link to Full-Text
Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-CPerdiguero BPloS ONE20139/1/2013Link to Full-Text
Multidonor analysis reveals structural elements, genetic determinants and maturation pathway for HIV-1 neutralization by VRC01-class antibodiesZhou TImmunity20138/22/201323911655Link to full-text
Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1.Pace, Craig, SProceedings of the National Academy of Sciences20138/13/201323878231Link to Full Text
Single-dose vaccine against tick-borne encephalitisRumyantsev AAProceedings of the National Academy of Sciences of the United States of America20138/6/2013Link to full-text
Isolate-Specific Differences in the Conformational Dynamics and Antigenicity of HIV-1 gp120Davenport, Thaddeus, M.Journal of Virology20137/31/201323903848Link to full-text
Mixture models for single-cell assays with applications to vaccine studies.Finak GBiostatistics20137/24/201323887981Link to full-text
Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strainsChuang GYJournal of Virology20137/10/201323843642Link to full-text
Temperature fluctuations during deep temperature cryopreservation reduce PBMC recovery, viability and T-cell functionGermann ACryobiology20137/9/2013    23850825Link to full-text
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate.Visciano MLJ Transl Med. 2013 Jul 820137/8/2013    23835244Link to full-text
Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses. Pollara, J.Current HIV Research20137/2/201324191939 Link to full-text
Editorial (Thematic Issue: Fc Receptor-Mediated Effector Functions in the Humoral Control of HIV-1 Infection)DeVico ACurrent HIV Research20137/1/2013Link to full-text
Editorial (Thematic Issue: Fc Receptor-Mediated Effector Functions in the Humoral Control of HIV-1 Infection)DeVico, Anthony LCurrent HIV Research20137/1/201324191941Link to full-text
Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodiesLewis GKCurrent HIV Research20137/1/2013Link to full-text
Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.Lewis, George K.Current HIV research20137/1/201324191940Link to full-text
Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees.Liu, P.Journal of Virology20137/1/201323658446Link to full-text
Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] ResponsesPollara BCurrent HIV Research20137/1/2013Link to full-text
Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses.Pollara, JustinCurrent HIV Research20137/1/201324191939Link to full-text
Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] ResponsesPollara, JustinCurrent HIV Research20137/1/201324191939Link to full-text
Protective antiviral antibodies that lack neutralizing activity: precedents and evolution of conceptsSchmaljohn ALCurrent HIV Research20137/1/2013Link to full-text
Protective antiviral antibodies that lack neutralizing activity: precedents and evolution of concepts.Schmaljohn, Alan LCurrent HIV Research20137/1/201324191933Link to full-text
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residuesWest Jr APProceedings of the National Academy of Sciences20136/25/201323754383Link to full-text
Anti-HIV isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission. Watkins JDAIDS20136/23/201323775002Link to full-text
Computational analysis of anti–HIV-1 antibody neutralization panel data to identify potential functional epitope residuesWest, Jr., Anthony, P.Proceedings of the National Academy of Sciences of the United States of America20136/10/201323754383Link to full-text
Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques.Demberg TVirology20136/5/201323528732 Link to full-text
Novel directions in HIV-1 vaccines revealed from clinical trialsExcler JLCurrent Opinion in HIV AIDS20136/5/201323743791Link to full-text
Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness.Nowroozalizadeh SHum Vaccin Immunother. 2013 Jun 4;9(10). [Epub ahead of print]20136/4/2013    23912942Link to full-text
Broadly neutralizing antiviral antibodiesCorti DAnnual Review Immunology20136/1/2013In processLink to full-text
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission.Watkins JDAIDS20136/1/201323775002Link to full-text
Highly multiplexed quantitation of gene expression on single cells.Dominguez MHJournal of Immunological Methods20135/31/201323500781Link to full-text
Highly multiplexed quantitation of gene expression on single cellsDominguez, Maria HJournal of Immunological Methods20135/31/2013    23500781Link to Full text
Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccineesLiu, PinghuangProceedings of the National Academy of Sciences20135/28/201323658446Link to full-text
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgGTomaras GDProceedings of the National Academy of Sciences of the United States of America20135/28/2013 23661056Link to Full Text
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Tomaras, GD & Ferrari, GProceedings of the National Academy of Sciences20135/28/201323661056Link to full-text
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgGTomaras, Georgia Proceedings of the National Academy of Sciences of the United States of America PNAS, Proceedings of the National Academy of Sciences20135/28/201323661056Link to full text
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.Tomaras, Georgia DProceedings of the National Academy of Sciences20135/28/201323661056Link to full-text
Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodiesDiskin, RonJournal of Experimental Medicine20135/27/201323712429Link to full-text
Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms.Hansen SGScience20135/24/2013Link to Full Text
Cytomegalovirus vectors violate CD8+ Tcell epitope recognition paradigmsHansen, Scott G.Science20135/24/201323704576Link to full-text
High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.Mild MInfect Genet Evol. 2013 May 11. 20135/11/2013    23672855Link to full-text
Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals. Andrabi, R.Virology20135/10/201323466102Link to full-text
Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccineesLiu PJournal of Virology20135/8/2013 19004953Link to full-text
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activityAckerman, Margaret EThe Journal Of Clincial Investiagtion20135/1/201323563315Link to full-text
Enchanced Phagoytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for Fc gR2a and Fcg R2bAckerman, Margaret EJournal of Virology20135/1/201323468489 Link to full-text
Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes. Hoffenberg, S.Journal of Virology20135/1/2013 23468492Link to full text
Quality control, analysis and secure sharing of Luminex immunoassay data using the open source LabKey Server platform. Eckels, J. BMC Bioinformatics20134/30/201323631706Link to full-text
Engineering recombinant reoviruses with tandem repeats and a tetravirus Demidenko, Aleksander, AProceedings of the National Academy of Science USA20134/29/201323630248Link to Full Text
Pathogenesis and Treatment of HIV Infection: The Cellular, the Immune System and the Neuroendocrine Systems PerspectiveChereshnev VAInt Rev Immunol.20134/25/2013    23617796Link to full-text
Impact of immune complex size and glycosylation on IgG binding to human FcγRs.Lux, AnjaJournal of Immunology20134/15/201323509345Link to full-text
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX® B/ERerks-Ngarm SJournal of Infectious Disease20134/15/201322837492Link to Full Text
Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire.Casazza JPJournal of Infectious Disease20134/11/201323482645Link to Full Test
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodyScharf LProceedings of the National Academy of Sciences20134/9/201323524883Link to full-text
HIV: Roadmaps to a vaccineMouquet HNature20134/3/2013Link to full-text
R5 human immunodeficiency virus type 1 with efficient DC-SIGN use is not selected for early after birth in vertically infected children.Borggren M, Navér L, Casper C, Ehrnst A, Jansson M.J Gen Virol. 2013 Apr20134/1/2013    23223619Link to full-text
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralizationKlein FCell20133/28/201323540694Link to full-text
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodyScharf, LouiseProceedings of the National Academy of Sciences of the United States of America20133/22/201323524883Link to full-text
Polyinosinic-Polycytidylic Acid Is the Most Effective TLR Adjuvant for SIV Gag Protein-Induced T Cell Responses In Nonhuman PrimatesPark, HaesunJournal of Immunology20133/15/201323509365Link to Full Text
Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector ImmunizationQuinn KMThe journal of Immunology20133/15/2013Link to full-text
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition.Lutje Hulsik DPLos Pathogen20133/9/201323505368Link to full-text
Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.Özkaya Şahin GAIDS Res Hum Retroviruses. 2013 Mar;29(3):470-8. doi: 10.1089/AID.2012.0219. Epub 2012 Nov 21.20133/1/2013    23088167Link to full-text
Data exploration, quality control and testing in single-cell qPCR-based gene expression experiments McDavid ABioinformatics20132/15/201323267174Link to full-text
Data exploration, quality control and testing in single-cell qPCR-based gene expression experimentsMcDavid, AndrewBioinformatics20132/15/2013    23267174Link to Full text
Antibody-Dependent, FcʏRI-Mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosisPerez, L.G. Journal of Virology20132/13/201323408628 Link to full text
Neutralizing antibodies to HIV-1 induced by immunizationMcCoy LEJournal of Experimental Medicine20132/11/201323401570Link to full-text
Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays Bachy, VeroniqueProceedings of the National Academy of Sciences of the United States of America 20132/5/201323386724Link to Full Text
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2Liao, Hua-XinImmunity20131/24/201323313589Link to full-text
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. Zolla-Pazner SPLoS One20131/17/2013 3547933Link to full-texgt
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial. Zolla-Pazner, S. PLoS One 20131/13/201323349725Link to full-text
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingGuan YProceedings of the National Academy of Sciences of the United States of America20131/2/2013Link to full-text
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingGuan, YongjunProceedings of the National Academy of Sciences of the United States of America20131/1/201323237851Link to full-text
Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.Özkaya Şahin G, Holmgren B, Sheik-Khalil E, da Silva Z, Nielsen J, Nowroozalizadeh S, Månsson F, Norrgren H, Aaby P, Fenyö EM, Jansson M.J Virol. 2013 Jan;87(1):273-8120131/1/2013    23077299Link to full-text
Anti-CD4 monoclonal antibody ibalizumab exhibits breadth and potency against HIV-1, with natural resistance mediated by the loss of a V5 glycan in envelopePace CS and Fordyce MWJournal of Acquired Immune Deficiency Syndromes20131/1/201323023102Link to full-text
Systemic vaccination induces clonally diverse SIV-specific CD8+ T-cell populations in systemic and mucosal compartmentsSircar, PiyaMucosal Immunology20131/1/201322763409Link to full-text
An automated HIV-1 Env-pseudotyped virus production for global HIV vaccine trials.Schultz APLoS One. 2012201212/27/2012    23300558Link to full-text
Data Exploration, Quality Control and Testing in Single-Cell qPCR-Based Gene Expression ExperimentsMcDavid, AndrewBioinformatics201212/24/201223267174Link to Full text
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies.Donaldson, Mitzi, MJournal of Immunological Methods201212/14/201222955212Link to Full Text
HIV therapy by a combination of broadly neutralizing antibodies in humanized miceKlein FNature201212/6/201223103874Link to full-text
Comparability and reproducibility of biomedical dataHuang YBriefings in Bioinformatic201212/3/201223193203Link to Full Text
The Thai phase III HIV-1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120. Karasavvas, N. AIDS Research & Human Retroviruses201211/28/201223035746Link to full-text
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion.Alam, S MunirJournal of Virology201211/21/201223175357Link to full-text
Comparative analysis of SIV Gag specific effector and memory CD8 T cells induced by different adenovirus vectors. Tan WGJournal of Virology201211/21/201223175355 Link to full-text
Comparative analysis of SIV Gag specific effector and memory CD8 T cells induced by different adenovirus vectorsTan WGJournal of Virology201211/21/201223175355 Link to full-text
Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectorsTan, Wendy G.Journal of Virology201211/21/201223175355Link to full-text
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodiesMouquet, HugoProceedings of the National Academy of Sciences of the United States of America201211/20/201223115339Link to full-text
Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectorsPenaloza-Macmaster PJournal of Virology201211/14/201223152535 Link to full-text
Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectorsPenaloza-Macmaster PJournal of Virology201211/14/201223152535 Link to full-text
Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity. Zak, Daniel, E., and Andersen-Nissen, EricaProceedings of the National Academy of Sciences of USA201211/14/201223151505Link to Full Text
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). Barouch DHJournal of Infectious Desiease201211/2/201223125443 Link to full-text
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). Barouch DHJournal of Infectious Desiease201211/2/201223125443 Link to full-text
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).Barouch DHJournal of VIrology201211/2/201223125443Link to full text
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene FamilyBonsignori MJournal of Virology201211/1/2012Link to full-text
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family.Bonsignori, MattiaJournal of Virology201211/1/201222896626Link to full-text
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family.Bonsignori, MattiaJournal of Virology201211/1/201222896626Link to full-text
HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design.Bonsignori, Mattia, Trends In Microbiology201211/1/201222981828Link to full-text
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape.Moore, P.L.Nature Medicine201211/1/2012 23086475 Link to full text
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodiesMouquet, Hugo and Scharf, LouiseProceedings of the National Academy of Sciences of the United States of America201210/30/201223115339Link to full-text
Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci.Pruzina SProtein Engineering, Design and Selection201210/24/201221810921Link to full-text
Fragmentation of SIV-gag vaccine induces broader T cell responsesBenlahrech, AdelPLoS One201210/21/201223118924Link to Full Text
A blueprint for HIV vaccine discoveryBurton DCell Host & Microbe201210/18/201223084910Link to full-text
Skin tattooing as a novel approach for DNA vaccine deliveryChiu YNJournal of visualized experiments: JoVE201210/18/201223117298Link to full-text
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2Rolland MNature201210/18/201222960785 Link to full-text
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120Karasavvas NAIDS Research and Human Retroviruses201210/4/201223035746Link to Full Text
Complex-type N-glycan recognition by potent broadly-neutralizing HIV antibodiesMouquet HProceedings of the National Academy of Sciences201210/4/201223115339Link to full-text
Profiles of neutralizing antibody responses in chronically HIV-1 clade B' infected former plasma donors naïve to ART in Central China. Hu, X. Journal of General Virology201210/1/201222791603 Link to full text
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens.Wegmann FrankNature Biotechnology20129/30/201222922673Link to full-text
High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samplesMargaret Ackerman Journal of Immunological Methods20129/27/201223023091Link to full-text
A mouse model for HIV-1 entryPietzsch JProceedings of the National Academy of Sciences USA20129/25/201223014910Link to full-text
Enumeration of major peripheral blood leukocyte populations for multicenter clinical trials using a whole blood phenotyping assayHensley, Tiffany, R.Journal of Visualized Experiments20129/16/201223007739Link to full-text
Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.Karlsson UAIDS. 2012 Sep 10;26(14):1739-44. doi: 10.1097/QAD.0b013e3283560791.20129/10/2012     22695299Link to full-text
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines.Fukazawa YNature Medicine20129/9/201222961108Link to Full Text
CD4 T follicular helper cell dynamics during SIV infectionPetrovas, ConstantinosJournal of Clinical Investigation20129/4/201222922258Link to Full text
Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparationsKolibab, KristopherJournal of Microbiological Methods20129/1/201222652432Link to full-text
Enhanced priming of adaptive immunity by high secretor mutants of Mycobacterium smegmatisTaylor, NatalieClinical and Vaccine Immunology20129/1/201222787192Link to full-text
Human Hybridoma TechnologyGorny Miroslaw K.Antibody Technology Journal20128/31/2012Link to full-text
Towards a xeno-free and fully chemically defined cryopreservation medium for maintaining viability, recovery, and antigen-specific functionality of PBMC during long-term storage.Schulz JCJ Immunol Methods. 2012 Aug 31;382(1-2):24-31. Epub 2012 May 8.20128/31/201222580762Link to full text
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studiesDonaldson MJournal of Immunological Methods20128/28/2012 22955212Link to full-text
Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.Manches, OlivierProceedings of the National Academy of Sciences of USA20128/28/201222879398PNAS Full Text
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene familyBonsignori, MJournal of Virology20128/15/201222896626Link to Full Text
Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys. Stephenson KEJournal of Virology20128/15/201222896617Link to full-text
Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeysStephenson KEJournal of Virology20128/15/201222896617 Link to full-text
Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys.Stephenson,KEJournal of Virology20128/15/2012PMC3486282Link to full-text
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope proteinKlein FJournal of Experimental Medicine20127/30/201222826297Link to full-text
Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity Sholukh AMPLosOne20127/30/201222737224Link to full-text
A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular ImmunityPattacini LPLoS One20127/25/2012Link to full-text
A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular ImmunityPattacini, LauraPLoS One20127/25/201222848738Link to full text
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120West Jr Anthony PProceedings of the National Academy of Sciences20127/24/201222745174Link to full-text
Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.Esbjörnsson JN Engl J Med. 2012 Jul 19;367(3):224-32.20127/19/201222808957Link to full-text
Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeysLi HJournal of Virology20127/18/201222811531 Link to full-text
Clonal analysis of human anti-V3 monoclonal antibodies selected by a V3 tetramerGorny, Miroslaw K. Human Antibodies20127/11/2012PMC3708495Link to Full-text
Milk Matters: Soluble Toll-Like Receptor 2 (sTLR2) in Breast Milk Significantly Inhibits HIV-1 Infection and Inflammation. Henrick Bethany M.PLoS ONE20127/7/201222792230Find in PLoS ONE
Comparing and combining data across multiple sources via integration of paired-sample data to correct for measurement errorHuang YStatistics In Medicine20127/5/201222764070Link to Full Text
Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following SIV challenges of vaccinated rhesus monkeys.Stephenson KEJournal of Virology20127/3/201222761379 Link to full-text
Vaccination with adenovirus serotypes 35, 26, and 48 elicits greater innate cytokine responses than adenovirus serotype 5 in rhesus monkeysTeigler JEJournal of Virology20127/3/201222761379 Link to full-text
New CD1d agonists: Synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramidesJervis, Peter JBioorganic & Medicinal Chemistry Letters20127/1/2012PMID: 22652050Link to full-text
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120West, Anthony, PProceedings of the National Academy of Sciences of the United States of America20126/27/201222745174Link to full-text
Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subjectGorny Mirek K. PLoS One20126/25/2012PMC3382572Link to full-text
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunizationMcCoy LEJournal of Experimental Medicine20126/4/201222641382Link to full-text
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. Montefiori, D.C.The Journal of Infectious Diseases20126/1/201222634875Find in JID
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. Montefiori, David, CJournal of Infectious Diseases20126/1/201222634875 Link to full-text
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144Robb MLLancet Infect Diseases20125/30/201222652344Link To Full Text
Statistical approaches to analyzing HIV-1 neutralizing antibody assay data Yu, XStatistics in biopharma research20125/24/201224660049 Link to full-text
Accelerated heterologous adenovirus prime-boost SIV vaccine in neonatal rhesus monkeysLiu JJournal of Virology20125/16/201222593160 Link to full-text
International network for comparison of HIV neutralization assays: the NeutNet report II.Heyndrickx LPLoS One. 2012;7(5):e36438. Epub 2012 May 9.20125/9/2012    22590544Link to full text
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineagesMoody, Michael AJournal of Virology20125/2/201222553329Link to full-text
Mycobacteria-infected bystander macrophages trigger maturation of dendritic cells and enhance their ability to mediate HIV transinfection.Mazurek JEur J Immunol. 2012 May;42(5):1192-202. doi: 10.1002/eji.201142049.20125/1/2012    22539293Link to full text
BCG: myths, realities, and the need for alternative vaccine strategiesMcShane, HelenTuberculosis (Edinb)20125/1/201222349516Link to full-text
Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human PlasmaSajadi MMJournal of Virology20125/1/2012Link to full-text
Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteinsSajadi, Mohammad M.Journal of Virology20125/1/201222379105Link to full-text
Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provideRolland MAIDS Research and Human Retroviruses20124/28/201221902593Link to Full Text
Systems Analysis of MVA-C Induced Immune Response Reveals its Significance as a Vaccine Candidate Against HIV/AIDS of Clade C. Gómez CEPLoS One20124/19/2012Link to full-text
Altering an Artificial Gagpolnef Polyprotein and Mode of ENV Co-Administration Affects the Immunogenicity of a Clade C HIV DNA VaccineBöckl KPLoS One20124/11/2012Link to full-text
The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization. Brown, B.K.PLoS One20124/11/201222509241Find in PLoS One
Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund’s AdjuvantsLai, Rachel P. J.PLos One20124/11/201222509385Find in PLos ONE
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialHaynes BFNew England Journal of Medicine20124/5/2012Link to full-text
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialHaynes, Barton F. The New England Journal of Medicine20124/5/201222475592Find in New England Journal of Medicine
Immune-correlates analysis of an HIV-1 vaccine efficacy trialHaynes, Barton, FNew England Journal Of Medicine20124/5/201222475592Link to full-text
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.Haynes, BHNew England Journal of Medicine20124/5/201222475592Link to Full Text
Preexisting adenovirus seropositivity is not associated with increased HIV-1 acquisition in three HIV-1 vaccine efficacy trialsStephenson KEJournal of Infectious Desiease20124/5/201222492863 Link to full-text
Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of VaccinationCheng CPLoS ONE20124/4/2012e0033969Find in PLoS ONE
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNasesCocchi FProceedings of the National Academy of Sciences of the United States of America20124/3/2012Link to full-text
Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop AntibodiesAlmond, DavidAdvances in virology20124/2/2012PMC3323838Link to full-text
A deep profiler's guide to cytometryBendall, Sean CTrends in Immunology20124/2/201222476049Find in Trends in Immunology
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4. Falkowska, E.Journal of Virology20124/2/201222345481Find in Journal of Virology
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.Cocchi, FiorenzaProceedings of the National Academy of Sciences of the United States of America20124/1/201222431590Link to full-text
Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cellsDrannik Anna GJournal of Virology20124/1/201222345469Find in Journal of Virology
HIV-1 virus-like particles bearing pure Env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes. Tong, T.Journal of Virology20124/1/201222301141Link to full-text
OMIP-005: Quality and phenotype of antigen-responsive rhesus macaque T cells.Foulds, KathrynCytometry A20123/21/201222438313Find in Cytometry A
OMIP-009: Characterization of antigen-specific human T-cells.Lamoreaux, LaurieCytometry A20123/21/201222438322 Find in Cytometry A
Formulation of a mmaA4 Gene Deletion Mutant of Mycobacterium bovis BCG in Cationic Liposomes Significantly Enhances Protection against TuberculosisDerrick, Steven CPLoS One20123/19/201222442674Link to full-text
Llama Antibody Fragments Recognizing Various Epitopes of the CD4bs Neutralize a Broad Range of HIV-1 Subtypes A, B and CStrokappe, Nika PLos One20123/15/201222438910Find in PLoS One
Virus inhibition activity of effector memory CD8+ T cells determines Simian Immunodeficiency Virus load in vaccinated monkeys after vaccine breakthrough infectionYamamoto, TakuyaJournal of Virology20123/14/201222419810Find in J Virology
Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals.Gorny, Miroslaw K.Virology20123/7/201222402248Find in ScienceDirect
Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates.Kwissa, MarcinBlood20123/1/201222246032Blood Fulltext
Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.Ochsenbauer, C. Journal of Virology20123/1/2012 22190722Link to full text
Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human Plasma.Sajadi, MJournal of Virology20122/29/201222379105Link to Full Text
Llama antibody fragments have good potential for application as HIV type 1 topical microbicidesGorlani AAIDS Research and Human Retroviruses20122/28/201221864083 Find in Full Text
Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 VaccineQureshi H, Journal of Virology20122/8/201222156519Link to Full Text
Immunogenetics of spontaneous control of HIV. Carrington, M & Walker, BDAnnual Review of Medicine20122/1/201222248321Link to full-text
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccineJing LJ Clin Invest.20122/1/2012Link to full-text
Tuberculosis and HIV co-infection.PLoSPathog. 2012 Feb;8(2):e1002464. Pawlowski APLoSPathog. 2012 Feb;8(2):e1002464. 20122/1/201222363214Link to full text
Dendritic cell-targeted protein vaccines: a novel approach to induce T cell immunity.Trumpfheller, C.Journal of Internal Medicine20122/1/20123261312Find in Wiley
In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG.Venkataswamy MMVaccine20122/1/201222189700Find in PubMed Central
Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys.Kaufman DRVaccine20121/11/201222133509Find in ScienceDirect
Dissecting the HIV-specific immune response:a systems biology approachPeretz, YoavCurrent Opinion in HIV and AIDS20121/7/201222134339Find in OvidSP
An open-ended plea for the development of a global database of HIV vaccine responsesWilkinson PCurrent Opinion in HIV and AIDS20121/7/201222156846Find in OvidSP
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.Barouch DHNature20121/4/201222217938 Link to full-text
The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques. Wang, Y. PLoS One20121/2/201222031951Link to full text
Profiling immunity to HIV vaccines with systems biology.Andersen-Nissen, EricaCurrent Opinion in HIV and AIDS20121/1/201222134340Link to Full Text
Systems vaccinology: its promise and challenge for HIV vaccine development.Nakaya, Helder I.Current Opinion in HIV & AIDS20121/1/201222156839Link to full-text
International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials. Ozaki, D.A. and Gao, H. PLoS One20121/1/201222303476Find in PLoS One
Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1Ozkaya Sahin GJ Virol. 2012 Jan;86(2):961-71. 20121/1/201222072782Link to full text
HIV-specific CD4 cell responses to different viral proteins have discordant associations with viral load and clinical outcomeRanasinghe, SJournal of Virology20121/1/201222031937Link to Full Text
Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteinsSellhorn, GeorgeJournal of Virology20121/1/201222031951Find in Journal of Virology
Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development.Zak, Daniel E.Current Opinion in HIV & AIDS20121/1/201222156843Current Opinion in HIV & AIDS
HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in miceZaharatos, GJVaccine201112/9/201122064264Find in Science Direct
Enhanced HIV-1 neutralization by antibody heteroligationMouquet HProceedings of the National Academy of Sciences of the USA201112/6/201122219363Link to full-text
Increasing the potency and breadth of an HIV antibody by using structure-based rational designDiskin RScience201112/2/201122033520Link to full-text
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational DesignDiskin, RonScience201112/2/201122033520Full text
Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure. Gorny, Miroslaw K.PLoS One201112/2/201122164215Link to Full-text
A sequential phase 2b trial design for evaluating vaccine efficacy and immune correlates for multiple HIV vaccine regimens. Statistical Communications in Infectious DiseasesGilbert, PStatistical Communications in Infectious Diseases201112/1/2011naLink to full-text
Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp120 and Human CD4 ProteinsLewis GKJouornal of Virology201112/1/2011Link to full-text
Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteinsLewis, George K.Journal of Virology201112/1/201121994452Link to full-text
Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41Dennison, SMPLoS One201111/30/201122140469Find in Plos One
Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infectionBradley RRJournal of Virology201111/9/2011 22072776Find in Journal of Virology
Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regionsBradley RRJournal of Virology201111/9/201122072746Find in Journal of Virology
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humansCaskey, MarinaThe Journal of Experimental Medicine201111/7/201122065672Find in JEM
Indirect detection of an epitope-specific response to HIV-1 gp120 immunization in human subjectsShmelkov EPLoS One201111/4/201122076145Link to full-text
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformationAlam, MunirJournal Of Virology201111/1/201121917975Journal of Virology
Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectorsBandaranayake, Ashok D. Nucleic Acids Research201111/1/201121911364Find in Oxford Journals
High-resolution structure prediction of a circular permutation loopCorreia, Bruno E.Protein Science201111/1/201121898647 Link to full-text
Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals. Tomaras, G.D.Journal of Virology201111/1/201121849452Find in Journal of Virology
Differential regulations of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cellsScheid JProceedings of the National Academy of Sciences USA201110/24/201122025722Link to full-text
Computation-guided backbone grafting of a discontinuous motif onto a protein scaffoldAzoitei, Mihai L. Science201110/21/201122021856Find in Science
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralizationKim, MikyungNature structural & molecular biology201110/16/201122002224Find in Nature
Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteins.Lewis, GKJournal of Virology201110/12/201121994452Link to Full Text
Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtained.Balla-Jhagjhoorsingh SSPLoS One201110/10/201122016769Link to full-text
Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea PigsKhattar SKJournal of Virology201110/1/2011Link to full-text
DNA-C/NYVAC-C vaccine regimen induces HIV-specific CD4 and CD8 T cell-responses in intestinal mucosaPerreau MJ Virol.201110/1/2011Link to full-text
Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.Verkoczy, LaurentJournal of Immunology201110/1/201121908739Find in Journal of Immunology
A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop.Ringe, R.Virology20119/30/201121851958Find in ScienceDirect
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells. Todd CAJournal of Immunologic Methods20119/22/201121968254Find in Science
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cellsTodd CAJournal of Immunological Methods20119/22/201121968254Link to Full Text
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells. Todd, C.A. and Greene, K.M.Journal of Immunological Methods20119/22/201121968254Find in ScienceDirect
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative SubjectsBaden LRJournal of Infectious Diseases20119/21/201121940420Link to full-text
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding.Scheid, JFScience20119/16/201121764753Science
Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys.Li HJournal of Virology20119/14/201121917969Journal of Virology
Memory B cell antibodies to HIV-1 gp 40 cloned from individuals infected with clade A and B virusesMouquet HPloS One20119/8/201121931643Link to full-text
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.Sweeney KANature Medicine20119/4/201121892180Find in PubMed Central
Standardized Serum-Free Cryomedia Maintain Peripheral Blood Mononuclear Cell Viability, Recovery, and Antigen-Specific T-Cell Response Compared to Fetal Calf Serum-Based MediumGermann ABiopreserv Biobank. 2011 Sep;9(3):229-236.20119/1/2011    21977240Link to full text
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodiesMa, BJPlos Pathogens20119/1/201121909262Link to full-text
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodiesZhu, ZhongyuJournal of Virology20118/31/201121880764Find in Journal ov Virology
The role of dynamin in HIV type 1 Env-mediated cell-cell fusion.Lai, W.AIDS Research and Human Retroviruses20118/23/201121338326Find in Liebert Online
B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses. Oballah, P. PLoS One20118/23/201121886768Find in PLoS One
Vitamin A deficiency impairs vaccine-elicited gastrointestinal immunity.Kaufman DRJournal of Immunology20118/15/201121765014Find in Journal of Immunology
Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin translociPruzina SProtein Engineering, Design and Selection20118/2/201121810921Find in PubMed
Construction and phenotypic characterization of HIV-1 functional envelope clones of subtypes G and F. Revilla, A. AIDS Research and Human Retroviruses20118/1/201121226626Find in Liebert Online
Designed oligomers of cyanovirin-N show enhanced HIV neutralizationKeeffe, Jennifer R.Proceedings of the National Academy of Sciences of the USA20117/28/201121799112PDF from HighWire Press
Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens Following Priming with gp120 DNA. Zolla-Pazner, SusanVirology20117/27/201121795338Journal of Virology
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccineIrvine, Darrell JJournal of Control Release20117/24/201121820024Find in Science Direct
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.Barouch DHVaccine20117/18/201121619905Find in ScienceDirect
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingScheid JScience20117/14/201121764753Link to full-text
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 BindingScheid, Johannes F. Science20117/14/201121764753Find in Science Express
Systems biology of vaccination for seasonal influenza in humansNakaya, Helder, I.Nature Immunology20117/10/201121743478Find in Nature Immunology
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Pollara J Cytometry Part A: The Journal of the International Society for Analytical Cytology20117/6/201121735545Link to full-text
A novel high throughput quantitative platform to detect functional HIV-1 and SIV-specific antibody dependent cellular cytotoxicity (ADCC)-mediating antibody responses. Pollara, J. Cytometry20117/6/201121735545Wiley Online Library
TLR4 engagement during TLR3-induced pro-inflammatory signaling in dendritic cells promotes IL-10-mediated suppression of anti-tumor immunityBogunovic, DusanCancer Research20117/5/201121730023Find in Cancer Research
Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms. Nofemela, A.Virology20117/2/2011 21531432Link to Full Text
Binding interactions between soluble HIV envelope glycoproteins and quaternary-structure-specific monoclonal antibodies PG9 and PG16Davenport, Thaddeus M. Journal of Virology20117/1/201121543501Find in Journal or Virology
Phylogenetic structure in African HIV-1 subtype C revealed by selective sequential pruning. Thomson, M.M.Virology20116/20/201121507449Find in ScienceDirect
Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun.Bagley, KCClinical and Vaccine Immunology20116/18/201121508173Link to Full Text
Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Envglycosylation and chargeBorggren MPLoSOne. 2011;6(6):e20135. Epub 2011 Jun 1620116/16/201121698221Find in PubMed Central
Helical peptide arrays for lead identification and interaction site mappingLangedijk JPAnalytical Biochemistry20116/12/201121708118Find in Science Direct
Retinoic Acid as a Vaccine Adjuvant Enhances CD8+ T Cell Response and Mucosal Protection from Viral ChallengeTan, XuefangJournal of Virology20116/8/201121653670Find in Journal of Virology
Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection.Lakhashe SKPLosOne20116/4/201121799765Link to full-text
Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimmers intact and viral infectivity unaffected. Crooks, E.T.Journal of Virology20116/1/201121471242Find in Journal of Virology
Synergistic Inhibition of R5 HIV-1 by Maraviroc and CCR5 Antibody HGS004 in Primary Cells: Implications for Treatment and PreventionLatinovic OAIDS London Journal20116/1/2011Link to full-text
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodiesVerkoczy, LaurentCurrent Opinion in Immunology20116/1/201121524897Link to full-text
LabKey Server NAb: a tool for analyzing, visualizing and sharing results from neutralizing antibody assaysPiehler BBMC Immunology20115/27/201121619655Find in PubMed Central
Immunological mechanisms of vaccinationPulendran, BaliNature Immunology20115/18/201121739679Find in Nature Immunology
In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy VolunteersVasan, SPLoS ONE20115/16/201121603651PLoS ONE
Sequence analysisof HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.Vinner LAPMIS20115/14/201121749448 Link to full-text
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineHansen, Scott, G.Nature20115/11/201121562493Find in Nature
Structural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120Spurrier BrettStructure20115/11/201121565703Link to full-text
Structural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120. Spurrier, BrettStructure20115/11/201121565703Link to Full-Text
A HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent ADCC activity and defines a common ADCC activity in human HIV-1 serum. Ferrari, G. Journal of Virology20115/4/20111543485Find in Journal of Virology
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in MonkeysLetvin NLScience Translational Medicine20115/4/201121543722Find in Science
The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.Gray, ESJournal of Virology20115/2/201121389135Find in the Journal of Virology
Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activityantibody activitSajadi MMJournal of Acquired Immune Deficiency Symdromes20115/1/2011Link to full-text
Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.Sajadi, MJournal of Acquired Immunodeficiency Syndromes20115/1/201121283016Link to Full Text
Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.Sajadi, Mohammad MJournal of acquired immune deficiency syndromes (1999)20115/1/201121283016Link to full-text
Improved NYVAC-based vaccine vectorsKibler KVPLoS One20114/29/2011Link to full-text
Prime-boost immunization with proteín targeted to the dendritic cell receptor DEC205 followed by recombinant NYVAC induces robust Gag CD4 and CD8+ T cell responses in non human primatesFlynn B.JProc Natl Acad Sci U S A20114/26/2011Link to full-text
HLA/KIR Restraint of HIV: Surviving the Fittest.Bashirova, AAAnnual Review of Immunology20114/23/201121219175Find in Annual Review of Immunology
Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28Pufnock, Jeff, S.Blood20114/22/201121493800Find in Blood Journal
HIV-1 vaccines and adaptive trial designsCorey LScientific Translational Medicine20114/20/201121508308     Find in Science
Immunization with Recombinant HLA Class I and II, HIV-1 gp140 and SIV p27 Elicits Protection against Heterologous SHIV Infection in Rhesus Macaques.Mörner AJ Virol, 85:6442-52, 2011.20114/13/201121490092Link to full-text
Development of a tier 1 R5 clade C simian-human immunodeficiency virus as a tool to test neutralizing antibody-based immunoprophylaxis.Siddappa NBJ Med Primatology20114/6/201121044092link to full-text
Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy TrialsGilbert PBJournal of Infectious Disease20114/1/201121402548Find in Oxford Journals
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVWatkins JDPLoS One20113/31/201121483815Find in PLOS One
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV.Watkins JDPLosOne20113/31/201121483815Link to full-text
An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Watkins Jennifer D. PLoS One20113/31/201121483815Full Text
A Rapid Fluorescence-Based Assay for Classification of iNKT Cell Activating GlycolipidsArora, PJournal of American Chemical Society20113/22/201121425779Find in PubMed
Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.Julg, BJournal of Infectious Diseases20113/15/201121257739Find in Journal of Infectious Diseases
Epithelial adhesion molecules inhibit HIV-1-specific CD8+ T-cell functions.Streeck, HBlood20113/14/201121403126Fin in Blood
Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasmacytoid dendritic cells to HIV-1.Chang, J.JAIDS20113/13/201121297422Find in AIDS
Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice.Maamary, JJournal of Virology20113/1/201121159873Journal of Virology
Programming the magnitude and persistence of antibody responses with innate immunityKasturi, Sudhir, P.Nature20112/23/201121350488Find in Nature
Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotypeO'Brien, MeaganJournal of Clinical Investigation20112/21/2011PMC3049388Find in Journal of Clinical Investigation
Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm.Tranell AVirus Res. 2011 Feb 21. 20112/21/201121345357 Find in ScienceDirect
Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm.Tranell AVirus Res. 2011 Apr;157(1):82-91. Epub 2011 Feb 21.20112/21/201121345357Find in Science Direct
Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active diseaseHarari, AlexandreNature Medicine20112/20/201121336285Find in Nature Medicine
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responsesMoon JJNature Materials20112/20/201121336265Find in PubMed Central
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expression NYVAC vectorsQuakkelaar, E.PLoS One20112/15/201121347234PLoS One
Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 InfectionFerrari GPLoS Pathogens20112/10/201121347345Link to Full Text
Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.Kim, A.YGastroenterology20112/1/201120875418Find in Gastroenterology
Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120. Kirchherr, J.L.Virology20111/20/201121036380Find in ScienceDirect
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffoldTotrov, MaximVirology20111/20/201120663531Find in Science Direct
Next-generation sequencing for HLA typing of class I lociErlich, RLBMC Genomics20111/18/201121244689Find in BMC Genomics
Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporationDolter KEVaccine20111/17/201121094270Find in Vaccine
HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function.Chevalier, MFJournal of Virology20111/15/201121047960Find in Journal of Virology
CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cellsFranco DJournal of Acquired Immune Deficiency Syndromes20111/13/201121239998Find in Journal of Acquired Immune Deficiency Syndromes
Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis. Hinchey, JPLoS One20111/10/201121264335Find in PybMed
Quantitative assessment of masking of neutralization epitopes in HIV-1Agarwal, AVaccine20111/7/201121216319Find in Science Direct
Computational protein design using flexible backbone remodeling and resurfacing: case studies in structure-based antigen designCorreia, Bruno E.Journal of Molecular Biology20111/7/201120969873Find in Elsevier
Structural conservation predominates over sequence variability in the crown of HIV type 1's V3 loopAlmond DavidAIDS Res Hum Retroviruses20111/6/201120560796Find in AIDS Research
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in art-naïve actg clinical trials participants.Grady, BJPac Symp Biocomput20111/1/201121121053Find in Pac Symp Biocomput
Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization EpitopesSwetnam, JamesPLoS One201012/29/201021209919Find in PLoS One
Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes.Swetnam, JamesPLoS One201012/29/201021209919Find in PLoS One
Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvantPadte NNClinical Immunology201012/23/201021185784Clinical Immunology
Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies.Frey, GaryNature Structural and Molecular Biology201012/17/201021076402 Find in Nature
Equivalence of ELISpot Assays Demonstrated Between Major HIV Network Laboratories.Gill KD,  Huang Y, PLoS ONE201012/14/201021179404Find in PLoS One
Equivalence of ELISpot assays demonstrated between major HIV network laboratoriesGill, Dilbinder, KPLoS ONE201012/14/201021179404Find in PLoS ONE
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.International HIV Controllers StudyScience201012/10/201021051598Find in Science Magazine
Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibodyFreeman MMStructure201012/8/201021134642Find in Science Direct
Replication competent molecular clones of HIV-1 expressing renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Edmonds, T.G.Virology201012/5/201020863545Find in Elsevier
Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody.Freeman, M.M. Structure201012/1/201021134642Find in Science Direct
IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.Martin, MPJournal of Infectious Diseases201012/1/201020977343Find in Journal of Infectious Diseases
HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer.Martin, MPImmunogenetics201012/1/201020857097Find in Immunogenetics
Cytolytic CD4(+) T cells in viral immunity.Soghoian, DZExpert Review of Vaccines201012/1/201021105780Find in Expert Review of Vaccines
B cell responses to HIV-1 infection and vaccination: pathways to preventing infectionHaynes, Barton FTrends in Molecular Medicine201011/26/201021112250 Find in ScienceDirect
Non-neutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigensDennison, S, MJournal of Virology201011/24/201021106741Find in Journal of Virology
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells.Jähnichen SProc Natl Acad Sci U S A201011/23/201021059953Pharmacology
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external regionNicely, Nathan, INature Structural & Molecular Biology201011/14/201021076400Find in Nature Publishing Group
Flow cytometry sorting of recombinant mycobacterial species yields bacterial clones with enhanced insert expression. Yu, JSClinical and Vaccine Immunology201011/10/201021068210Find in PubMed
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation.The International HIV Controllers StudyScience201011/4/201021051598Science
Neutralisation activity in a geographically diverse East London cohort of HIV-1 infected patients: Clade C infection results in a stronger and broader humoral immune response than clade B infection.Dreja, H. Journal of General Virology201011/1/201020685933Find in Journal of General Virology
Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2Hiby, SEThe Journal of Clinical Investigation201011/1/201020972337Find in The Journal of Clinical Investigation
Determinants of protection among HIV‐exposed seronegative persons: an overview.Lederman, M.MJournal of Infectious Diseases201011/1/201020887220Find in Journal of Infectious Diseases
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41.Sabin, C. PLoS Pathogens201011/1/201021124990Find in PubMed Central
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41. Sabin, C. PLoS Pathogens201011/1/201021124990Find in PLoS Pathogens
Induction of immunity to human immunodeficiency virus type-1 by vaccination.McElrath, M. JulianaImmunity201010/29/201021029964Find in Immunity
Systems vaccinology.Pulendran, BaliImmunity201010/29/201021029962Find in Immunity
Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children.Cavarelli MAIDS. 2010 Oct 23;24(16):2527-33.201010/23/201020683317Find in Lippincott Williams & Wilkins Database
Multiple innate immune pathways contribute to the immunogenicity of recombinant adenoviral vaccine vectors.Rhee, EGJournal of Virology201010/20/201020962088Find in Journal of Virology
Maternal human leukocyte antigen A*2301 is associated with increased mother-to-child HIV-1 transmission.Mackelprang, R.DJournal of Infectious Diseases201010/15/201020812845Find in Journal of Infectious Diseases
MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction.Nolting, AVirology201010/10/201020667578Find in Virology
Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.Tranell AJ Biol Chem. 2010 Oct 8;285(41):31537-47. Epub 2010 Aug 4.201010/8/201020685659Find in PubMed
Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. Gnanakaran, S.PLoS Computational Biology201010/7/201020949103Find in PLoS Computational Biology
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligationMouquet HNature20109/30/201020882016Nature
Polyreactivity increasess the apparent affinity of anti-HIV antibodies by heteroligationMouquet HNature20109/30/201020882016Link to full-text
Human anti-HIV neutralizing antibodies frequently target a conserved epitope essential for viral fitnessPietzsch JJournal of Experimental Medicine20109/30/201020678402Link to full-text
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.Totrov, M. Virology20109/30/201020663531Find in Science Direct
Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection. Ringe, R. Retrovirology20109/22/201020860805Find in Retrovirology
High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa.Månsson FInt J STD AIDS. 2010 Sep;21(9):631-5.20109/21/201021097735 Find in PubMed
Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.Tomescu, CAIDS20109/10/201020647906Find in AIDS
Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitopeCorreia, Bruno E.Structure20109/8/201020826338Find in Elsevier Science
Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy.Ozkaya Sahin GPLoS Pathog. 2010 Sep 2;6(9):e1001084.20109/2/201020824092Find in PLoS Pathogens
Novel adenovirus vector-based vaccines for HIV-1Barouch, DHCurrent Opinion in HIV & AIDS20109/1/2010n/aLink to full-text
Leukocyte Immunoglobulin-Like Receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1 elite controllersHuang, JJournal of Virology20109/1/201020631139Find in Journal of Virology
Novel subtype C human immunodeficiency virusKoh Willie W. L.Journal of General Virology20109/1/201020484560Find in Journal of General Virology
Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activationMcCoy LEJournal of General Virology20109/1/201020444990Journal of General Virology
Strategies for eliciting HIV-1 inhibitory antibodies.Tomaras, G.D.Current Opinion in HIV and AIDS20109/1/201020978384Find in OvidSP
New monoclonal anti-mouse DC-SIGN antibodies reactive with acetone-fixed cells.Cheong, CJournal of Immunological Methods20108/31/201020558171Journal of Immunological Methods
Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.Yindom, LMJournal of Virology20108/31/201020519398Find in Journal of Virology
Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitnessPietzsch JJournal of Experimental Medicine20108/30/201020679402Find in PubMed Central
Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responsesAlmeidaa, C.Vaccine20108/23/201020619380ScienceDirect
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.Gilbert, Peter BJournal of Infectious Diseases 20108/15/201020608874Find in Journal of Infectious Diseases
Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection. Lynch, R.M.Virology20108/15/2010 20494390Find in ScienceDirect
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.Wu, X. Science20108/13/201020616233Find in Science
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01Zhou TScience20108/13/201020616231Link to full-text
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development.Franco, DVaccine20108/9/201020600494Find in Vaccine
Evidence of dysregulation of dendritic cells in primary HIV infection.Sabado, Rachel L.Blood20108/6/201020693428Find in Blood
Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5. Masek-Hammerman, KJournal of Virology20108/4/201020686023Find in Journal of Virology
Serine- and arginine-rich protein 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.Tranell, A.Journal of Bio Chemistry20108/4/201020685659 Find in JBC
Human anti-HIV-neutralizing antibodies frequently target a conserved epitope esential for viral fitness.Pietzsch, J.The Journal of Experimental Medicine20108/2/201020679402Find in Journal of Experimental Medicine
Impaired replication capacity of acute/early viruses in persons who become HIV controllers.Miura, TJournal of Virology20108/1/201020504921Find in Journal of Virology
Limited contribution of mucosal IgA to SIV-specific neutralizing antibody response and virus Envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys.Permar, S.R.Journal of Virology20108/1/201020519381Find in Journal of Virology
Epigenetic regulation of telomerase expression in HIV-1-specific CD8+ T cells.Williams, KAIDS20107/31/201020588158 Find in Lippincott Williams & Wilkins Database
Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children.Cavarelli, M.AIDS20107/30/201020683317 Find in AIDS
Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tubLázár-Molnár E,Proceedings of the National Academy of Sciences (USA)20107/27/201020624978Find in PNAS
MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction.Nolting, AVirology20107/26/201020667578Find in ScienceDirect
A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicityKlein, Joshua S.AIDS20107/17/201020597163Find in AIDS
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllersJulg, BClinical Infectious Diseases: an official publication of the Infectious Diseases Society of America20107/15/201020550452 Find in U Chicago Journals
TLR4 Ligands Augment Antigen-Specific CD8+ T Lymphocyte Responses Elicited by a Viral Vaccine Vector.Rhee EGJournal of Virology20107/14/201020631129Find in Journal of Virology
Conserved structural elements in the V3 crown of HIV-1 gp120Xunqing JiangNat Struct Mol Biol20107/11/201020622876Find in Nature
CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signalingLindsay, Ross, W.B.Journal of Immunology20107/7/201020610651Find in Journal of Immunology
Challenges of antibody-mediated protection against HIV-1Lewis GKExpert Review of Vaccines20107/1/2010Link to full-text
Challenges of Antibody Mediated Protection Against HIV-1Lewis, GKExpert Reviews of Vaccines20107/1/201020624038Full to Full Text
Epitope mapping of ibalizumab, a humanized anti-CD4 monoclonal antibody with anti-HIV-1 activity in infected patients.Song, R and Franco, DJournal of Virology20107/1/201020463063Find in Journal of Virology
Mycobacterium tuberculosis Dihydrofolate Reductase is Not a Target Relevant to the Anti-tubercular Activity of IsoniazidWang, FAntimicrobial Agents and Chemotherapy20106/21/201020566771Find in PubMed
Synthesis and biological activity of alpha-glucosyl C24:0 and C20:2 ceramidesJervis PJ,Bioorganic & Medicnal Chemistry Letters20106/15/201020529677Find in PubMed
Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteriaPruksakorn, P.Bioorganic & Medicinal Chemistry Letters20106/15/201020483615 Find in PubMed
High sexual risk taking and diverging trends of HIV-1 and HIV-2 in the military of Guinea Bissau.Biague, A.Journal of Infection in Developing Countries20106/3/201020539062 Find in JIDC
IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection.Alter, GThe Journal of Clinical Investigation20106/1/201020440075Find in JCI
Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralizationBinley, J.M.Journal of Virology20106/1/201020335257Find in Journal of Virology
Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralizationBinley, James M.Journal of Virology20106/1/201020335257 Find in J Virol
Breadth of HIV-specific neutralizing activity in sera: Clustering analysis and association with clinical variables.Doria-Rose, N.AJournal of Virology20106/1/201019923174 Find in Journal of Virology
Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.Julg, B.Journal of Virology20106/1/201020335261Find in Journal of Virology
Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.Kaufman, DHJournal of Virology20106/1/201020357087Find in Journal of Virology
A significant transmission bottleneck among newly and recently HIV-1 infected injection drug users in St. Petersburg, Russia.Masharsky, A.E.Journal of Infectious Diseases20106/1/201020423223Find in Journal of Infectious Diseases
Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.Hersperger, AR.PLoS Pathogens20105/27/201020523897Find in PubMed Central
Few and Far Between: How HIV May Be Evading Antibody AvidityKlein, Joshua S.PLoS Pathogens20105/27/201020523901 Find in PLoS Pathog
Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.Deneberg, S.Leukemia20105/24/201020237504 Find in Leukemia
Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infectionKosmrlj, A.Nature20105/20/201020445539Find in Nature
Variation Among Genome Sequences of H37Rv Strains of M. tuberculosis from Multiple Laboratories Ioerger, TRJournal of Bacteriology20105/14/201020472797Find in Journal of Bacteriology
High multiplicity infection by HIV-1 in men who have sex with men.Li, H.PLoS Pathogens20105/13/201020485520 Find in PLoS Pathogens
Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.Buzon, V.PLoS Pathology20105/6/201020463810Find in PLoS Path
Crystal Structure of the Neutralizing Llama VHH D7 andHinz, AndreasPLos One20105/5/201020463957Find in PLoS One
HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention?Haynes, Barton F.Nature Structural and Molecular Biology20105/1/201020442740Find in Nature
Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity.Pietzsch, J.Journal of Virolgoy20105/1/201020219932 Find in Journal of Virology
Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1Zhang, MymAbs20105/1/201020305395 Find in Landes BioScience
The role of antibodies in HIV vaccines. Mascola, J. R.Annual Review of Immunology20104/23/201020192810Link to full-text
Synthesis and biological activity of alpha-L-fucosyl ceramides, analogues of the potent agonist, alpha-D-galactosyl ceramide KRN7000Veerapen NBioorganic & Medicinal Chemistry Letters20104/22/201020462758Find in PubMed
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes. Hioe, C.E.PLoS One20104/21/201020421997PLoS One
Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 SubtypesHioe, CatarinaPLoS One20104/21/201020421997Find in PLoS One
GENERATION OF A FAMILY-SPECIFIC PHAGE LIBRARY OF LLAMA SINGLE CHAIN ANTIBODY FRAGMENTS THAT NEUTRALIZE HIV-1Koh, Willie W.L.The Journal of Biological Chemistry20104/16/201020400507Find in JBC
Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.Nowroozalizadeh, S.Journal of Infectious Diseases20104/15/201020199244 Find in Journal of Infectious Diseases
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines.Moody, AnthonyThe Journal of Experimental Medicine20104/12/2010 20368576Find in JEM
Wide variation in the multiplicity of HIV-1 infection among injection drug usersBar, K.J.Journal of Virology20104/7/201020375173Find in Journal of Virology
Performance of serum-supplemented and serum-free media in IFN Elispot Assays for human T cells Janetzki, SylviaCancer Immunology, Immunotherapy20104/1/201019894047Find in CII
A Hidden Markov Model Approach for Inference of Immunoglobulin Rearrangements. Munshaw, SupriyaBioinformatics20104/1/201020147303Link to full-text
Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. Diskin, RNature Structural & Molecular Biology20103/31/201020357769Nature Structural & Molecular Biology
Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeysYeh, W.W.Journal of Virology20103/31/201020357097Find in Journal of Virology
Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.Geonnotti, A. R.AIDS Research and Human Retroviruses20103/24/201020218881 Find in AIDS Research
Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.Esbjörnsson, J.Retrovirology20103/22/201020307309 Find in Retrovirology
Immunology and the elusive AIDS vaccineVirgin, HWNature20103/11/201020220841Find in Nature
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Barouch, D.H.Nature Medicine20103/1/201020173752 Nature Medicine
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeysBarouch, DHNature Medicine 20103/1/201020173752Find in PubMed
Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clonesHoll, TMJournal of Immunological Methods20103/1/201020109461 Find in Science Direct
Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitutionShen XProceedings of the National Academy of Sciences20103/1/201020231447PNAS
NAD(+) Auxotrophy is bacteriocidal for the Tubercle BacilliVilchèze CMol Microbiol 20102/28/201020199601Inter Science
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Neutralizing Antibody AssessmentSeaman MJournal of Virology20102/15/201019939925Link to Full Text
HIV-1 vaccine development after STEPBarouch DHAnnual Review20102/1/201020059334Annual Review
Syntheses and biological activities of KRN7000 analogues having aromatic residues in the acyl and backbone chains with varying stereochemistryPark, JJBioorganic & Medicinal Chemistry Letters20102/1/201020061147Find in PubMed Central
Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.Shen, X.Proceedings of the National Academy of Sciences20102/1/201020231447 Find in PNAS
Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4Robinson, JEJournal of Virology20101/27/201020106929Journal of Virology
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. Corti, D.PLoS One20101/20/201020098712PLoS One
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1.Nandi, A.Journal of Virology20101/20/201019922969 ScienceDirect
The immune response during acute HIV-1 infection: clues for vaccine development.McMichael, A.J.Nature Reviews Immunology20101/10/201020010788Find in Nature Reviews Immunology
Differential specificity and immunogenicity of Adenovirus 5 neutralizing antibodies elicited by natural infection or immunization.Cheng CJournal of Virology20101/7/201019846512Journal of Virology
Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine designZolla-Pazner SusanNat Rev Immunol20101/7/201020577269Find in Nature
Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs.Nkolola, J.P.Journal of Virology20101/6/201020053749Journal of Virology
Breadth of Neutralizing Antibodies Elicited by Stable, Homogeneous Clade A and Clade C HIV-1 gp140 Envelope Trimers in Guinea PigsNkolola, Joseph P.Journal of Virology20101/6/201020053749Link to full-text
. Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance.Verkoczy LProceedings of the National Academy of Sciences20101/5/2010 20018688 PNAS
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens Moutaftsi, M.Future Microbiology20101/2/201020143946 Future Medicine
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected IndividualsCorti, DavidePLoS One20101/1/201020098712PLoS One
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune ControlFerreira, MAAmerican Journal of Human Genetics20101/1/201020045101Find in PubMed Central
Potential role for ESAT6 in dissemination of M Tuberculosis via human human lung epithelial cellsKinhikar AGMol Microbiol20101/1/201019906174Inter Science
Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1.Salisch, NCJournal of Immunology20101/1/201019949078Find in Journal of Immunology
Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cellsSullivan, BAJournal of Immunology20101/1/201019949076Find in Journal of Immunology
Evaluation of CD4-CD4i Antibody Architectures Yields Potent, Broadly Cross-Reactive Anti-Human Immunodeficiency Virus ReagentsWest, Anthony P.Journal of Virology20101/1/201019864392Find in J Virol
Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfectionSellhorn GVaccine200912/11/200919857451Vaccine
Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M tuberculosis in neonatal miceRanganathan UDVaccine200912/10/200919808028Science Direct
A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.Kraus, M.H.Journal of Virology200912/8/200920003995Journal of Virology
Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120Forsman, AJournal of Virology200912/1/200918842738 PubMed Central
Role of HIV membrane in neutralization by two broadly neutralizing antibodies.Alam, SMProceedings of the National Academy of Sciences 200911/11/200919906992PNAS
Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Benlahrech, AProceedings of the National Academy of Science United States of America200911/6/200919918060PNAS
Maturation Pathways of Cross-Reactive HIV-1 Neutralizing AntibodiesXiaodong XiaoViruses200911/6/2009n/aLink to full-text
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. Seaman M.S.Journal of Virology200911/5/200919939925Journal of Virology
Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region.Verkoczy LPLoS One200910/6/200919806186PLoS One
Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regionsDennison, SMJournal of Virology200910/1/200919640992 JV Online
HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected childrenCavarelli, MPLoS ONE20099/29/200918820725 PLoS ONE
Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.Nascimento IPScience Direct20099/25/200919782111Science Direct
HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infectionBonsignori , MJournal of Virology20099/15/200919625640JV Online
ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humansJing, LJournal of Immunological Methods20099/15/200919520082 PubMed Central
Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parametersPereyra , FJournal of Infectious Diseases20099/15/200919656066UofC Press Online
Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parametersPereyra, FJournal of Infectious Diseases20099/15/200919656066Find in Chicago Journals
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing theZolla-Pazner, SVirology20099/15/2009 19632700ScienceDirect
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogensXiaodong XiaoBiochemical and Biophysical Research Communications20099/11/200919748484ScienceDirect.com
Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activityXu HJournal of Virology20099/11/200919906921Journal of Virology
Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses. Cranage, M.P.Mucosal Immunology20099/9/200919741600Mucosal Immunology
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins. Gao, F.Virology20099/9/200919744690Virology
Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.Rong, R.PLoS Pathogens20099/5/200919763269PLoS Pathogens
Specificities of broadly neutralizing anti-HIV sera.Binley, J. Current Opinion in HIV and AIDS20099/4/2009 20048699 Current Opinion in HIV and AIDS
The implications of patterns of HIV diversity for neutralizing antibody induction and susceptibility. Korber, B.Current Opinion in HIV and AIDS20099/4/200920048705Current Opinion in HIV and AIDS
Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need? Montefiori, D. C.Current Opinion in HIV and AIDS20099/4/200920048696Current Opinion in HIV and AIDS
New virologic reagents for neutralizing antibody assays. Ochsenbauer, C.Current Opinion in HIV and AIDS20099/4/200920048706Current Opinion in HIV and AIDS
Impact of host-cell variation on the neutralization of HIV-1 in vitro. Polonis, V. R.Current Opinion in HIV and AIDS20099/4/200920048704Current Opinion in HIV and AIDS
Challenges for structure-based HIV vaccine designSchief, WRCurrent Opinion in HIV and AIDS20099/4/200920048708HIV and AIDS
HIV-1 specific antibody responses during acute and chronic HIV-1 infection. Tomaras, G. D.Current Opinion in HIV and AIDS20099/4/200920048700Current Opinion in HIV and AIDS
Immunogenicity of HIV-1 envelope glycoprotein oligomersForsell, Mattias NECurrent Opinion in HIV & AIDS20099/1/200920048701Find in Current Opinion HIV AIDS
Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins Go, EPJournal of Proteome Research20099/1/200919610667 ACS
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donorsGray, ES Journal of Virology20099/1/200919553335 Find in PubMed
Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndromeKuraoka, MJournal of Immunology20099/1/200919667096JV Online
Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-GuerinVenkataswamy, MMJournal of Immunology20099/1/200919620317Journal of Immunology Online
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins.Brumme ZLPLoS One20098/19/200919690614Find in PLoS One
Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region.Gray, E.S.Journal of Virology20098/19/200919692477Journal of Virology
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Stamatatos, L.Nature Medicine20098/15/200919525964Nature Medicine
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1Kang, YKVaccine20098/13/200919567243 Science Direct
Systemic and mucosal T lymphocyte activation induced by recombinant adenovirus vaccines in rhesus monkeys.Sun, Y Journal of Virology (ePub ahead of print)20098/5/200919656883 J of Virology Online
Modeling sequence evolution in acute HIV-1 infection.Lee, H.Y.Journal of Theoretical Biology20098/4/200919660475Journal of Theoretical Biology
Characterization of a trimeric MPER containing HIV-1 gp41 antigenHinz, AVirology 20098/1/200919539967Find in PubMed
Characterization of a trimeric MPER containing HIV-1 gp41 antigenHinz, AVirology20098/1/200919539967PubMed Central
T lymphocyte trafficking and vaccine-elicited mucosal immunityKuafman, DRClinical and Experimental Immunology20098/1/200919604255 Find in PubMed
Adenovirus-specific immunity following immunization with an Ad5 HIV-1 vaccine candidate in humansO'Brien, KLNature Medicine20098/1/200919620961 Find in PubMed
Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1Platt, EJJournal of Virology20098/1/200919474095Journal of Virology
Harnessing innate immunity for HIV vaccine developmentRhee, EGClinical and Experimental Immunology20098/1/200919604256 InterScience
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?Stamatatos, LNature Medicine20098/1/200919525964 Link to Full Text
Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cellsStreeck, HJournal of Virology20098/1/200919458000Find in Journal of Virology
Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primatesLarsen, MHVaccine20097/23/200919500524 Science Direct
Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.Li, XProceedings of the National Academy of Sciences of the United States of America20097/20/200920616071PNAS
Differential HIV Epitope Processing in Monocytes and CD4 T Cells Affects Cytotoxic T Lymphocyte RecognitionLazaro, EThe Journal of Infectious Diseases20097/15/200919505257
Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1Meier, ANature Medicine20097/13/200919597505
cells require a systemic type 1 interfereon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvantLonghi, M.P.Journal of Experimental Medicine20097/6/200919564349Journal of Experimental Medicine
Characterization of a trimeric MPER containing HIV-1 gp41 antigenHinz, AVirology20097/1/200919539967PubMed Central
Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosisParra, MClinical and Vacicne Immunology20097/1/200919458207 CVI Online
Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCHVelmourougane, GeethaBioorganic Medicine Chemistry Letter 20097/1/200919481452Find in PubMed Central
Delivery of adenovirus HIV vaccine vectors to the intestine induces enhanced mucosal cellular immunityWang, LJournal of Virology20097/1/200919420074 JV Online
Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cellsGeiger, R.Journal of Experimental Medicine20096/29/200919564353Journal of Experimental Medicine
3Conserved cryptic recombination signals in Vkappa gene segments are cleaved in small pre-B cellsLieberman, AEBMC Immunology20096/25/200919555491 PubMed Central
Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCerBai, LProceedings of the National Academy of Sciences (USA)20096/23/200919506241Find in PNAS
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.Delaloye, JPLoS Pathogens20096/19/200919543380 PubMed Central
Kinetics and cellular site of glycolipid loading control the outcome of Natural Killer T cell activationIm, JSImmunity20096/19/200919538930 PubMed Central
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccineKopecky-Bromberg, SAVaccine20096/8/200919464560 Find in PubMed
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interfaceSong, LProcedings of the National Academy of Sciences of the USA20096/2/200919458040 PNAS
Recombinant BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional SIV-specific T cell responses.Cayabyab, MJJournal of Virology20096/1/200919297477 Find in PubMed
Genetic identity, biological phenotype and evolutionary pathways of transmitted/founder viruses and their progeny in acute and early HIV-1 infection.Salazar-Gonzalez, J.F.Journal of Experimental Medicine20096/1/200919487424JEM
Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site.Dey, B.PLoS Pathogens20095/29/200919478876 Find in PLoS Pathogens
Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India.Kulkarni, SSVirology20095/15/200919167740 Find in PubMed
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersLambotte, OAIDS20095/15/200919414990 Find in PubMed
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.Davis, KLVirology20095/10/200919298995 Find in PubMed
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progressionWalley, NMCell, Host & Microbe20095/8/200919454339 Link to Full Text
HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. Wood, N.PLoS Pathogens20095/8/200919424423 PLoS Pathogens
Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10Klein, Joshua S.Proceedings of the National Academy of Sciences of the United States of America20095/5/200919372381Find in PNAS
Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical TrialsSarzotti-Kelsoe, MPLoS Medicine20095/5/200900000Link to full-text
Worldwide Distribution of HIV Type 1 Epitopes RecognizedCardozo, TAIDS Research and Human Retroviruses20094/25/200919320565 Find in AIDS Research
A critical role for CD8 T cells in a nonhuman primate model of tuberculosisChen, CYPLoS Pathogens20094/17/200919381260Find in PLoS Pathogens
Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infectionsNowroozalizadeh, SCytokine20094/16/200919375940 Find in PubMed
A method for identification of HIV gp140 binding memory B cells in human blood.Scheid, JFJournal of Immunological Methods20094/15/200919100741 Find in PubMed
Assessing Vaccine Effects in Repeated Low-Dose Challenge Experiments.Hudgens, MGBiometrics20094/13/200919397589Find in PubMed
Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infectionPrice DAJournal of Experimental Medicine20094/6/200919349463Find in JEM
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individualsScheid, JFNature20094/2/200919287373 Find in PubMed
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals Scheid, JFNature20094/2/200919287373Find in Nature
Multiply-deleted replication-defective adenovirus vectors do not induce measurable vector-specific T cells in human trials.Koup, RAJournal of Virology20094/1/200919339347 Find in PubMed
Transmission and Long-term Stability of Compensated CD8 Escape MutationsSchneidewind, AJournal of Virology20094/1/200919091871
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthShen, XJournal of Virology20094/1/200919193787 Find in PubMed
In Vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency type 1 neutralization breadth. Shen, XJournal of Virology20094/1/200919193787 Journal of Virology
HIV type 1 diversity: subtype differences in Env.Lynch, R.M.AIDS Research and Human Retroviruses20093/28/200919327047 Find in PubMed Central
Phenotype variation in human immunodeficiency virus type 1 transmission and disease progressionCavarelli MDisease Markers 20093/27/200919893208 Find in IOS
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccinationDavis, KLVirology20093/17/200919298995
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.Hansen, SGNature Medicine20093/1/200919219024
The role of IFN-gamma Elispot assay in HIV vaccine researchStreeck, HNature Protocols20093/1/200919282851
Safety and immunogenicity of the Mycobacterium tuberculosis DeltalysA DeltapanCD vaccine in domestic cats infected with feline immunodeficiency virusZimmerman, DMClinical and Vaccine Immunology20093/1/200919144788 PubMed Central
International network for comparison of HIV neutralization assays: the NeutNet reportFenyö, EMPLoS ONE20092/20/200919229336 PLoS ONE
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infectionGuan, YProceedings of the National Academy of Sciences20092/18/200919225108PubMed Central
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infectionGuan, YProceedings of the National Academy of Sciences of the United States of America20092/18/2009Link to full-text
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves.Waters, WRVaccine20092/18/200919135497 Find in PubMed
Effects of acute and chronic inflammation on B-cell development and differentiationCain, DJournal of Investigative Dermatology, the20092/1/200919148216
Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma.Davis, K.L.Journal of Virology20092/1/200919019969Find in Journal of Virology
Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasmaDavis, KLJournal of Virology20092/1/200919019969
Genetic correlates of autoreactivity and autoreactive potential in human Ig heavy chainsVolpe, JMImmunome Research20092/1/200919250530 PubMed Central
Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1Wang, YEJournal of Virology20092/1/200919036810
Antibody to Langerin/CD207 localizes large number of CD8 alpha+dendritic cells to the marginal zone of mouse spleenIdoyaga, J.Proceedings of the National Academy of Sciences of the USA20091/29/200919168629 PNAS
Distinct Profiles of Cytotoxic Granules in Memory CD8 T-Cells Correlate with Function, Differentiation Stage and Antigen Exposure.Harari, AJournal of Virology20091/28/200919176626Find in PubMed
Distinct Profiles of Cytotoxic Granules in Memory CD8 T-Cells Correlate with Function, Differentiation Stage and Antigen Exposure.Harari, AJournal of Virology20091/28/200919176626Find in PubMed
Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposureHarari, AJournal of Virology20091/28/200919176626 Link to Full Text
Differential Neutralization of HIV replication in Autologous CD4 T Cells by HIV-specific CTLChen, HJournal of Virology20091/21/200919158248
HLA Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite ControllersMiura, TJournal of Virology20091/19/200919153230
Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: implications for design of V3-based immunogensBurke ValiciaStructure20091/11/200919913488Find in Science Direct
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodiesLiao, HXJournal of Virological Methods20091/6/200919428587 Science Direct
Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses.Carnero, EJournal of Virology20091/1/200919004953Find in PubMed
Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.Ko, SYJournal of Virology20091/1/200918987146Find in PubMed
Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individualsLi, Y.Journal of Virology20091/1/200919004942 Find in Journal of Virology
Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR arrayLim, JClinical and Vaccine Immunology20091/1/200919038785 PubMed Central
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.Sather, DNJournal of Virology20091/1/200918987148
Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency.West, A.P.Journal of Virology20091/1/200918945777 Find in Journal of Virology
Design and Expression of a Dimeric Form of the Human Immunodeficiency Virus Type 1 Antibody 2G12 with Increased Neutralization PotencyWest, APJournal of Virology20091/1/200918945777
Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.Bueno, SMProceedings of the National Academy of Sciences200812/30/200819075247 Find in PubMed
Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCGBuenos, Susan M.Proc Natl Acad Sci, USA200812/30/200819075247Find in PNAS
HLA-B57/B*5801 HIV-1 Controllers Select for Rare GAG Variants Associated with Reduced Viral Replication Capacity and Strong CTL RecognitionMiura, TJournal of Virology200812/30/200819116253
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and CBinley JM Journal of Virology200812/15/200818815292Link to full-text
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and CBinley, JMJournal of Virology200812/1/200818815292Find in J Virol
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.Tomaras, GDJournal of Virology200812/1/200818842730 Find in PubMed
Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses.Qiu, LJournal of Infectious Diseases, The200811/15/200818811584 Find in PubMed
Comparison of multiple vaccine vectors in a single heterologous prime-boost trial.Barefoot, BVaccine200811/11/200818809447 Find in PubMed
Practical aspects of imputation-driven meta-analysis of genome-wide association studies.de Bakker, PIHuman Molecular Genetics200810/15/200818852200 Oxford Journals Online
Evaluating a surrogate endpoint at three levels, with application to vaccine development.Gilbert, PBStatistics in Medicine200810/15/200817979212PubMed Central
Challenges in the development of an HIV-1 vaccine.Barouch DHNature200810/2/200818833271Find in PubMed
Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccinationKaufman, DRJournal of Immunology20089/15/200818768876Find in PubMed
Polymer-supported lipid shells, onions, and flowersBershteyn, ASoft Matter20089/8/200819756178 PubMed Central
Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials.Shulman, NCytometry Part A: The Journal of the International Society for Analytical Cytology20089/1/200818615598Find in PubMed
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralizationCrooks, ETVirology20088/1/200818539308 PubMed Central
Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein.Irungu, JJournal of the American Society for Mass Spectrometry20088/1/200818565761
Characterization of the major histocompatibility complex class II DQB (MhcMamu-DQB1) alleles in a cohort of Chinese rhesus macaques (Macaca mulatta).Qiu, CLHuman Immunology20088/1/200818582516
Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccinationVaine, MJournal of Virology20088/1/200818495775 PubMed Central
A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response.Miconnet, IVaccine20087/29/200818562050
Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand.Park, JJBioorganic & Medicinal Chemistry Letters20087/15/200818586489 Find in PubMed
Combining human antisera to human leukocyte antigens, HIVgp120 and 70 kDa heat shock protein results in broadly neutralizing activity to HIV-1Babaahmady, KAIDS20087/11/200818580605
An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.Jing, LJournal of Virology20087/1/200818480455
An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profilingJing, LJournal of Virology20087/1/200818480455 PubMed Central
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.Zhang, MYJournal of Virology20087/1/200818480433PubMed Central
An IFN-gamma-IL-18 signaling loop accelerates memory CD8+ T cell proliferation.Iwai, YPLoS ONE20086/11/200818545704PLoS ONE
Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production.Dao, DNPLoS Pathogens20086/6/200818535659Link to full-text
An information-theoretic method for the treatment of plural ancestry in phylogenetics.Munshaw, SMolecular Biology & Evolution20086/1/200818359947
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionKeele, BFProceedings of the National Academy of Sciences20085/27/200818490657 PubMed Central
Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility.Go, EPJournal of Proteome Research20084/7/200818330979
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.Nelson, JDJournal of Virology20084/1/200817287272 PubMed Central
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencingSalazar-Gonzalez, JFJournal of Virology20084/1/200818256145 PubMed Central
Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infectionLester, RTAIDS20083/30/200818356597Find in PubMed
Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo.Idoyaga, JJournal of Immunology20083/15/200818322168Find in PubMed
Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelopeZolla-Pazner SVirology20083/15/200818061228Find in Science Direct
Focusing the Immune Response on the V3 Loop, a Neutralizing Epitope of teh HIV-1 gp120 EnvelopeZolla-Pazner, SusanVirology20083/15/200818061228Find in PubMed
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodiesFrey, GProceedings of the National Academy of Science20083/11/200818322015PubMed Central
Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infectionsIM, Jin SClinical Immunology20083/4/200818308638Find In PubMed Central
Towards prediction of degenerate CTL epitope recognitionLi, FHuman Vaccine20083/1/200818382130Find in PubMed
Large-scale analysis of human heavy chain V(D)J recombination patterns.Volpe, JMImmunome Research20082/27/200818304322Link to full-text
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionAlam, SMJournal of Virology20081/1/200817942537 Link to full-text
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionAlam, SMJournal of Virology20081/1/200817942537 Link to full-text
High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage.Brenchley, JMMucosal Immunology20081/1/200819079160Link to full-text
Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in miceDeLillo, DJJournal of Immunology20081/1/200818097037
HIV-1 hides an Achilles' heel in virion lipidsHaynes BFImmunity20081/1/200818199412
Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection.Huang, DInfection and Immunity20081/1/200817923514 Link to full-text
Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cells.Davila, MJournal of Experimental Medicine200712/24/200718056287Link to full-text
A framework for assessing immunological correlates of protection in vaccine trialsQin, LJournal of Infectious Diseases, The200711/1/200717922394 Link to full-text
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virusKwissa, MarcinJournal of Experimental Medicine200710/22/200717954572Link to full-text
Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.Wang, BZJournal of Virology200710/1/200717670815Link to full-text
Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infectionZheng, NNJournal of Virology20079/1/200717582003Link to full-text
Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosisHinchey, JJournal of Clinical Investigation, The20078/1/200717671656Link to full-text
High throughput functional analysis of HIV-1 env genes without cloning. Kirchherr, J.LJournal of Virology20077/1/200717416428Link to full-text
Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells.Velmurugan, KPLoS Pathogens20077/1/200717658950Link to full-text
Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.Yu, JSClinical & Vaccine Immunology20077/1/200717507541Link to full-text
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infectionGray, ESJournal of Virology20076/1/200717409164 Link to full-text
Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus.Jing, LJournal of Immunology20075/15/200717475867Link to full-text
Structural basis for coreceptor selectivity by the HIV type 1 V3 loopCardozo TAIDS Res Hum Retroviruses20075/4/200717411375Link to full-text
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopesAlam, SMJournal of Immunology20074/1/200717372000Link to full-text
Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent miceBhatt, AProceedings of the National Academy of Science20073/20/200717360388Link to full-text
Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.Lemiale, FVaccine20073/1/200717250935Link to full-text
Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.Bochud, PYAIDS20072/19/200717301562
Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccineDerrick, SCImmunology20072/1/200717076705Link to full-text
Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.Hovav, AHJournal of Virology20071/1/200717050608Link to full-text
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.Yu, JSClinical and Vaccine Immunology200611/1/200616943347 Link to full-text
For general questions about the CAVD or the content of the these pages, please contact alliance.management@cavd.org.
For technical issues with the website, please contact portalsupport@cavd.org.